{
  "label": "signal_outline",
  "artifact_type": "signal_outline",
  "artifact_id": "sha256:161174e8025b5c956602ccc4e17b4e677c58230b1b64641f357c400c448b8151",
  "input_ids": [
    "sha256:b4ba5337b06c8de68ac3315db1a4f6980c5bd48efd529c3914f30297d6afd329"
  ],
  "prompt_id": null,
  "model_config": null,
  "created_at": "2026-02-17T11:53:46.677866",
  "content": "{\n  \"episodes\": [\n    {\n      \"index\": 1,\n      \"date\": \"2024-03-04\",\n      \"enrollment\": {\n        \"total_randomized\": 40,\n        \"active\": 40,\n        \"screen_failures_cumulative\": 2,\n        \"withdrawals_cumulative\": 0,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 4,\n            \"active\": 4,\n            \"statin_concomitant\": 1\n          },\n          \"site_02\": {\n            \"enrolled\": 3,\n            \"active\": 3,\n            \"statin_concomitant\": 0\n          },\n          \"site_03\": {\n            \"enrolled\": 3,\n            \"active\": 3,\n            \"statin_concomitant\": 0\n          },\n          \"site_04\": {\n            \"enrolled\": 2,\n            \"active\": 2,\n            \"statin_concomitant\": 0\n          },\n          \"site_05\": {\n            \"enrolled\": 3,\n            \"active\": 3,\n            \"statin_concomitant\": 0\n          },\n          \"site_06\": {\n            \"enrolled\": 2,\n            \"active\": 2,\n            \"statin_concomitant\": 0\n          },\n          \"site_07\": {\n            \"enrolled\": 4,\n            \"active\": 4,\n            \"statin_concomitant\": 1\n          },\n          \"site_08\": {\n            \"enrolled\": 3,\n            \"active\": 3,\n            \"statin_concomitant\": 0\n          },\n          \"site_09\": {\n            \"enrolled\": 3,\n            \"active\": 3,\n            \"statin_concomitant\": 0\n          },\n          \"site_10\": {\n            \"enrolled\": 2,\n            \"active\": 2,\n            \"statin_concomitant\": 0\n          },\n          \"site_11\": {\n            \"enrolled\": 3,\n            \"active\": 3,\n            \"statin_concomitant\": 0\n          },\n          \"site_12\": {\n            \"enrolled\": 3,\n            \"active\": 3,\n            \"statin_concomitant\": 0\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 53,\n          \"alt_u_l\": {\n            \"mean\": 25.5,\n            \"median\": 22.7\n          },\n          \"ast_u_l\": {\n            \"mean\": 26.4,\n            \"median\": 24.4\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.78,\n            \"median\": 0.74\n          },\n          \"alp_u_l\": {\n            \"mean\": 84.9,\n            \"median\": 76.7\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.06,\n            \"median\": 0.95\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.9,\n            \"median\": 15.1\n          },\n          \"wbc_k\": {\n            \"mean\": 5.9,\n            \"median\": 7.6\n          },\n          \"platelets_k\": {\n            \"mean\": 233,\n            \"median\": 242\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 131,\n          \"alt_u_l\": {\n            \"mean\": 29.9,\n            \"median\": 28.9\n          },\n          \"ast_u_l\": {\n            \"mean\": 26.4,\n            \"median\": 25.9\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.73,\n            \"median\": 0.7\n          },\n          \"alp_u_l\": {\n            \"mean\": 71.9,\n            \"median\": 68.2\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.1,\n            \"median\": 0.98\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.8,\n            \"median\": 13.9\n          },\n          \"wbc_k\": {\n            \"mean\": 6.0,\n            \"median\": 7.8\n          },\n          \"platelets_k\": {\n            \"mean\": 218,\n            \"median\": 256\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0001\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0002\",\n          \"description\": \"nausea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0003\",\n          \"description\": \"headache\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0004\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 52,\n        \"ace_inhibitor_count\": 27,\n        \"metformin_count\": 23,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 12,\n        \"other_count\": 32\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-001\",\n          \"description\": \"Missed visit window (1 days late)\",\n          \"severity\": \"minor\",\n          \"site\": \"site_05\"\n        },\n        {\n          \"pd_id\": \"PD-002\",\n          \"description\": \"IP temperature excursion during shipment, 2h out of range\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_11\"\n        },\n        {\n          \"pd_id\": \"PD-003\",\n          \"description\": \"Lab sample mislabeled, corrected same day\",\n          \"severity\": \"minor\",\n          \"site\": \"site_08\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"IEC/IRB annual renewal submitted on schedule\",\n        \"Study drug accountability reconciled, no discrepancies\"\n      ],\n      \"events\": [\n        \"Central lab courier pickup schedule adjusted for holiday\",\n        \"Drug accountability audit at Site 08: no discrepancies\"\n      ],\n      \"notes\": \"Week 1: Enrollment proceeding per plan. Lab panels within reference ranges. Routine AEs only.\"\n    },\n    {\n      \"index\": 2,\n      \"date\": \"2024-03-11\",\n      \"enrollment\": {\n        \"total_randomized\": 60,\n        \"active\": 60,\n        \"screen_failures_cumulative\": 4,\n        \"withdrawals_cumulative\": 0,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 6,\n            \"active\": 6,\n            \"statin_concomitant\": 1\n          },\n          \"site_02\": {\n            \"enrolled\": 4,\n            \"active\": 4,\n            \"statin_concomitant\": 1\n          },\n          \"site_03\": {\n            \"enrolled\": 5,\n            \"active\": 5,\n            \"statin_concomitant\": 1\n          },\n          \"site_04\": {\n            \"enrolled\": 4,\n            \"active\": 4,\n            \"statin_concomitant\": 1\n          },\n          \"site_05\": {\n            \"enrolled\": 5,\n            \"active\": 5,\n            \"statin_concomitant\": 1\n          },\n          \"site_06\": {\n            \"enrolled\": 3,\n            \"active\": 3,\n            \"statin_concomitant\": 1\n          },\n          \"site_07\": {\n            \"enrolled\": 6,\n            \"active\": 6,\n            \"statin_concomitant\": 1\n          },\n          \"site_08\": {\n            \"enrolled\": 4,\n            \"active\": 4,\n            \"statin_concomitant\": 1\n          },\n          \"site_09\": {\n            \"enrolled\": 5,\n            \"active\": 5,\n            \"statin_concomitant\": 1\n          },\n          \"site_10\": {\n            \"enrolled\": 4,\n            \"active\": 4,\n            \"statin_concomitant\": 1\n          },\n          \"site_11\": {\n            \"enrolled\": 5,\n            \"active\": 5,\n            \"statin_concomitant\": 1\n          },\n          \"site_12\": {\n            \"enrolled\": 4,\n            \"active\": 4,\n            \"statin_concomitant\": 1\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 53,\n          \"alt_u_l\": {\n            \"mean\": 26.8,\n            \"median\": 26.3\n          },\n          \"ast_u_l\": {\n            \"mean\": 22.1,\n            \"median\": 20.8\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.73,\n            \"median\": 0.72\n          },\n          \"alp_u_l\": {\n            \"mean\": 71.0,\n            \"median\": 75.0\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.85,\n            \"median\": 0.93\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.6,\n            \"median\": 16.0\n          },\n          \"wbc_k\": {\n            \"mean\": 7.5,\n            \"median\": 7.0\n          },\n          \"platelets_k\": {\n            \"mean\": 236,\n            \"median\": 249\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 122,\n          \"alt_u_l\": {\n            \"mean\": 29.7,\n            \"median\": 28.0\n          },\n          \"ast_u_l\": {\n            \"mean\": 20.7,\n            \"median\": 20.0\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.9,\n            \"median\": 0.89\n          },\n          \"alp_u_l\": {\n            \"mean\": 56.7,\n            \"median\": 60.5\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.92,\n            \"median\": 0.82\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.0,\n            \"median\": 13.8\n          },\n          \"wbc_k\": {\n            \"mean\": 7.5,\n            \"median\": 6.8\n          },\n          \"platelets_k\": {\n            \"mean\": 233,\n            \"median\": 220\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0005\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0006\",\n          \"description\": \"nasopharyngitis\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0007\",\n          \"description\": \"nausea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 52,\n        \"ace_inhibitor_count\": 27,\n        \"metformin_count\": 23,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 12,\n        \"other_count\": 35\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-004\",\n          \"description\": \"IP temperature excursion during shipment, 2h out of range\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_02\"\n        },\n        {\n          \"pd_id\": \"PD-005\",\n          \"description\": \"Dose modification without documented PI approval\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_05\"\n        },\n        {\n          \"pd_id\": \"PD-006\",\n          \"description\": \"Informed consent version outdated by 1 revision\",\n          \"severity\": \"minor\",\n          \"site\": \"site_12\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Site pharmacy inventory verified\",\n        \"Subject retention rate within protocol targets\",\n        \"Study drug accountability reconciled, no discrepancies\"\n      ],\n      \"events\": [\n        \"Data management plan revision v2.5 distributed\",\n        \"Site 12 pharmacy temperature log reviewed: compliant\"\n      ],\n      \"notes\": \"Week 2: Enrollment proceeding per plan. Lab panels within reference ranges. Routine AEs only.\"\n    },\n    {\n      \"index\": 3,\n      \"date\": \"2024-03-18\",\n      \"enrollment\": {\n        \"total_randomized\": 80,\n        \"active\": 80,\n        \"screen_failures_cumulative\": 5,\n        \"withdrawals_cumulative\": 0,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 8,\n            \"active\": 8,\n            \"statin_concomitant\": 2\n          },\n          \"site_02\": {\n            \"enrolled\": 6,\n            \"active\": 6,\n            \"statin_concomitant\": 1\n          },\n          \"site_03\": {\n            \"enrolled\": 7,\n            \"active\": 7,\n            \"statin_concomitant\": 1\n          },\n          \"site_04\": {\n            \"enrolled\": 5,\n            \"active\": 5,\n            \"statin_concomitant\": 1\n          },\n          \"site_05\": {\n            \"enrolled\": 6,\n            \"active\": 6,\n            \"statin_concomitant\": 1\n          },\n          \"site_06\": {\n            \"enrolled\": 4,\n            \"active\": 4,\n            \"statin_concomitant\": 1\n          },\n          \"site_07\": {\n            \"enrolled\": 8,\n            \"active\": 8,\n            \"statin_concomitant\": 2\n          },\n          \"site_08\": {\n            \"enrolled\": 6,\n            \"active\": 6,\n            \"statin_concomitant\": 1\n          },\n          \"site_09\": {\n            \"enrolled\": 6,\n            \"active\": 6,\n            \"statin_concomitant\": 1\n          },\n          \"site_10\": {\n            \"enrolled\": 5,\n            \"active\": 5,\n            \"statin_concomitant\": 1\n          },\n          \"site_11\": {\n            \"enrolled\": 7,\n            \"active\": 7,\n            \"statin_concomitant\": 1\n          },\n          \"site_12\": {\n            \"enrolled\": 6,\n            \"active\": 6,\n            \"statin_concomitant\": 1\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 55,\n          \"alt_u_l\": {\n            \"mean\": 26.0,\n            \"median\": 24.3\n          },\n          \"ast_u_l\": {\n            \"mean\": 27.9,\n            \"median\": 25.9\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.59,\n            \"median\": 0.56\n          },\n          \"alp_u_l\": {\n            \"mean\": 79.3,\n            \"median\": 57.2\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.04,\n            \"median\": 0.9\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.6,\n            \"median\": 14.8\n          },\n          \"wbc_k\": {\n            \"mean\": 5.9,\n            \"median\": 6.5\n          },\n          \"platelets_k\": {\n            \"mean\": 245,\n            \"median\": 220\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 124,\n          \"alt_u_l\": {\n            \"mean\": 21.2,\n            \"median\": 20.6\n          },\n          \"ast_u_l\": {\n            \"mean\": 29.1,\n            \"median\": 28.2\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.54,\n            \"median\": 0.49\n          },\n          \"alp_u_l\": {\n            \"mean\": 73.5,\n            \"median\": 63.4\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.0,\n            \"median\": 0.99\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.2,\n            \"median\": 14.5\n          },\n          \"wbc_k\": {\n            \"mean\": 5.6,\n            \"median\": 6.4\n          },\n          \"platelets_k\": {\n            \"mean\": 229,\n            \"median\": 240\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0008\",\n          \"description\": \"fatigue\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0009\",\n          \"description\": \"headache\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0010\",\n          \"description\": \"fatigue\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 51,\n        \"ace_inhibitor_count\": 28,\n        \"metformin_count\": 21,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 13,\n        \"other_count\": 32\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-007\",\n          \"description\": \"Incorrect lab panel order, repeated\",\n          \"severity\": \"minor\",\n          \"site\": \"site_03\"\n        },\n        {\n          \"pd_id\": \"PD-008\",\n          \"description\": \"Concomitant medication not recorded at visit\",\n          \"severity\": \"minor\",\n          \"site\": \"site_04\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"All CRFs current through prior visit cycle\",\n        \"Query resolution rate at 94%\",\n        \"Lab kits inventory adequate for next 4 weeks\"\n      ],\n      \"events\": [\n        \"Central lab courier pickup schedule adjusted for holiday\",\n        \"Bioanalytical lab shipment tracking confirmed for 2 samples\",\n        \"Medical monitor weekly call completed\"\n      ],\n      \"notes\": \"Week 3: Enrollment proceeding per plan. Lab panels within reference ranges. Routine AEs only.\"\n    },\n    {\n      \"index\": 4,\n      \"date\": \"2024-03-25\",\n      \"enrollment\": {\n        \"total_randomized\": 100,\n        \"active\": 98,\n        \"screen_failures_cumulative\": 11,\n        \"withdrawals_cumulative\": 2,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 10,\n            \"active\": 10,\n            \"statin_concomitant\": 2\n          },\n          \"site_02\": {\n            \"enrolled\": 7,\n            \"active\": 7,\n            \"statin_concomitant\": 1\n          },\n          \"site_03\": {\n            \"enrolled\": 9,\n            \"active\": 9,\n            \"statin_concomitant\": 2\n          },\n          \"site_04\": {\n            \"enrolled\": 6,\n            \"active\": 6,\n            \"statin_concomitant\": 1\n          },\n          \"site_05\": {\n            \"enrolled\": 8,\n            \"active\": 8,\n            \"statin_concomitant\": 2\n          },\n          \"site_06\": {\n            \"enrolled\": 5,\n            \"active\": 5,\n            \"statin_concomitant\": 1\n          },\n          \"site_07\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 3\n          },\n          \"site_08\": {\n            \"enrolled\": 7,\n            \"active\": 7,\n            \"statin_concomitant\": 2\n          },\n          \"site_09\": {\n            \"enrolled\": 8,\n            \"active\": 8,\n            \"statin_concomitant\": 2\n          },\n          \"site_10\": {\n            \"enrolled\": 6,\n            \"active\": 6,\n            \"statin_concomitant\": 2\n          },\n          \"site_11\": {\n            \"enrolled\": 9,\n            \"active\": 9,\n            \"statin_concomitant\": 2\n          },\n          \"site_12\": {\n            \"enrolled\": 7,\n            \"active\": 7,\n            \"statin_concomitant\": 1\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 52,\n          \"alt_u_l\": {\n            \"mean\": 24.6,\n            \"median\": 23.8\n          },\n          \"ast_u_l\": {\n            \"mean\": 23.6,\n            \"median\": 23.2\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.86,\n            \"median\": 0.84\n          },\n          \"alp_u_l\": {\n            \"mean\": 73.7,\n            \"median\": 63.8\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.06,\n            \"median\": 0.92\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.3,\n            \"median\": 13.0\n          },\n          \"wbc_k\": {\n            \"mean\": 8.2,\n            \"median\": 5.5\n          },\n          \"platelets_k\": {\n            \"mean\": 235,\n            \"median\": 234\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 122,\n          \"alt_u_l\": {\n            \"mean\": 24.6,\n            \"median\": 23.1\n          },\n          \"ast_u_l\": {\n            \"mean\": 24.7,\n            \"median\": 22.8\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.7,\n            \"median\": 0.68\n          },\n          \"alp_u_l\": {\n            \"mean\": 59.4,\n            \"median\": 54.2\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.01,\n            \"median\": 0.8\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 14.8,\n            \"median\": 11.5\n          },\n          \"wbc_k\": {\n            \"mean\": 7.6,\n            \"median\": 7.0\n          },\n          \"platelets_k\": {\n            \"mean\": 243,\n            \"median\": 244\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0011\",\n          \"description\": \"nasopharyngitis\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0012\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 52,\n        \"ace_inhibitor_count\": 28,\n        \"metformin_count\": 23,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 13,\n        \"other_count\": 37\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-009\",\n          \"description\": \"Informed consent version outdated by 1 revision\",\n          \"severity\": \"minor\",\n          \"site\": \"site_05\"\n        },\n        {\n          \"pd_id\": \"PD-010\",\n          \"description\": \"Blood draw outside protocol-specified fasting window\",\n          \"severity\": \"minor\",\n          \"site\": \"site_06\"\n        },\n        {\n          \"pd_id\": \"PD-011\",\n          \"description\": \"Eligibility criterion reassessed, subject confirmed eligible\",\n          \"severity\": \"minor\",\n          \"site\": \"site_10\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"No new safety signals identified this week by local PI\",\n        \"Site pharmacy inventory verified\",\n        \"Query resolution rate at 94%\"\n      ],\n      \"events\": [\n        \"Data management plan revision v2.2 distributed\",\n        \"IVRS system update deployed, randomization unaffected\"\n      ],\n      \"notes\": \"Week 4: Enrollment proceeding per plan. Lab panels within reference ranges. Routine AEs only.\"\n    },\n    {\n      \"index\": 5,\n      \"date\": \"2024-04-01\",\n      \"enrollment\": {\n        \"total_randomized\": 120,\n        \"active\": 118,\n        \"screen_failures_cumulative\": 11,\n        \"withdrawals_cumulative\": 2,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 4\n          },\n          \"site_02\": {\n            \"enrolled\": 9,\n            \"active\": 9,\n            \"statin_concomitant\": 3\n          },\n          \"site_03\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 3\n          },\n          \"site_04\": {\n            \"enrolled\": 8,\n            \"active\": 8,\n            \"statin_concomitant\": 2\n          },\n          \"site_05\": {\n            \"enrolled\": 10,\n            \"active\": 10,\n            \"statin_concomitant\": 3\n          },\n          \"site_06\": {\n            \"enrolled\": 7,\n            \"active\": 7,\n            \"statin_concomitant\": 2\n          },\n          \"site_07\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          },\n          \"site_08\": {\n            \"enrolled\": 9,\n            \"active\": 9,\n            \"statin_concomitant\": 2\n          },\n          \"site_09\": {\n            \"enrolled\": 10,\n            \"active\": 10,\n            \"statin_concomitant\": 3\n          },\n          \"site_10\": {\n            \"enrolled\": 8,\n            \"active\": 8,\n            \"statin_concomitant\": 2\n          },\n          \"site_11\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 3\n          },\n          \"site_12\": {\n            \"enrolled\": 9,\n            \"active\": 9,\n            \"statin_concomitant\": 2\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 56,\n          \"alt_u_l\": {\n            \"mean\": 26.3,\n            \"median\": 25.5\n          },\n          \"ast_u_l\": {\n            \"mean\": 22.6,\n            \"median\": 22.4\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.67,\n            \"median\": 0.65\n          },\n          \"alp_u_l\": {\n            \"mean\": 68.6,\n            \"median\": 79.7\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.02,\n            \"median\": 0.97\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.6,\n            \"median\": 11.1\n          },\n          \"wbc_k\": {\n            \"mean\": 6.2,\n            \"median\": 6.1\n          },\n          \"platelets_k\": {\n            \"mean\": 258,\n            \"median\": 256\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 128,\n          \"alt_u_l\": {\n            \"mean\": 31.5,\n            \"median\": 30.6\n          },\n          \"ast_u_l\": {\n            \"mean\": 27.2,\n            \"median\": 25.6\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.7,\n            \"median\": 0.67\n          },\n          \"alp_u_l\": {\n            \"mean\": 73.4,\n            \"median\": 53.9\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.01,\n            \"median\": 0.98\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.0,\n            \"median\": 16.0\n          },\n          \"wbc_k\": {\n            \"mean\": 8.4,\n            \"median\": 6.4\n          },\n          \"platelets_k\": {\n            \"mean\": 251,\n            \"median\": 246\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0013\",\n          \"description\": \"dizziness\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0014\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0015\",\n          \"description\": \"arthralgia\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0016\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 53,\n        \"ace_inhibitor_count\": 28,\n        \"metformin_count\": 21,\n        \"ppi_count\": 17,\n        \"nsaid_count\": 12,\n        \"other_count\": 36\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-012\",\n          \"description\": \"Lab sample mislabeled, corrected same day\",\n          \"severity\": \"minor\",\n          \"site\": \"site_07\"\n        },\n        {\n          \"pd_id\": \"PD-013\",\n          \"description\": \"Lab sample mislabeled, corrected same day\",\n          \"severity\": \"minor\",\n          \"site\": \"site_05\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"IEC/IRB annual renewal submitted on schedule\",\n        \"Study drug accountability reconciled, no discrepancies\"\n      ],\n      \"events\": [\n        \"IVRS system update deployed, randomization unaffected\",\n        \"EDC system maintenance window: 2h downtime Saturday 02:00 UTC\"\n      ],\n      \"notes\": \"Week 5: Enrollment target met. All hepatic and renal panels within normal limits. 2 minor protocol deviations.\"\n    },\n    {\n      \"index\": 6,\n      \"date\": \"2024-04-08\",\n      \"enrollment\": {\n        \"total_randomized\": 140,\n        \"active\": 137,\n        \"screen_failures_cumulative\": 11,\n        \"withdrawals_cumulative\": 3,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_02\": {\n            \"enrolled\": 10,\n            \"active\": 10,\n            \"statin_concomitant\": 3\n          },\n          \"site_03\": {\n            \"enrolled\": 18,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 9,\n            \"active\": 9,\n            \"statin_concomitant\": 2\n          },\n          \"site_05\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 3\n          },\n          \"site_06\": {\n            \"enrolled\": 8,\n            \"active\": 8,\n            \"statin_concomitant\": 2\n          },\n          \"site_07\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_08\": {\n            \"enrolled\": 10,\n            \"active\": 10,\n            \"statin_concomitant\": 3\n          },\n          \"site_09\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 2\n          },\n          \"site_10\": {\n            \"enrolled\": 9,\n            \"active\": 9,\n            \"statin_concomitant\": 3\n          },\n          \"site_11\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 4\n          },\n          \"site_12\": {\n            \"enrolled\": 10,\n            \"active\": 10,\n            \"statin_concomitant\": 3\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 53,\n          \"alt_u_l\": {\n            \"mean\": 26.1,\n            \"median\": 24.7\n          },\n          \"ast_u_l\": {\n            \"mean\": 26.1,\n            \"median\": 25.3\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.83,\n            \"median\": 0.8\n          },\n          \"alp_u_l\": {\n            \"mean\": 61.2,\n            \"median\": 62.5\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.0,\n            \"median\": 1.0\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.6,\n            \"median\": 14.3\n          },\n          \"wbc_k\": {\n            \"mean\": 5.7,\n            \"median\": 7.4\n          },\n          \"platelets_k\": {\n            \"mean\": 253,\n            \"median\": 229\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 131,\n          \"alt_u_l\": {\n            \"mean\": 22.6,\n            \"median\": 22.0\n          },\n          \"ast_u_l\": {\n            \"mean\": 28.8,\n            \"median\": 28.1\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.48,\n            \"median\": 0.44\n          },\n          \"alp_u_l\": {\n            \"mean\": 72.8,\n            \"median\": 59.0\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.83,\n            \"median\": 0.99\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.5,\n            \"median\": 13.3\n          },\n          \"wbc_k\": {\n            \"mean\": 7.4,\n            \"median\": 6.4\n          },\n          \"platelets_k\": {\n            \"mean\": 249,\n            \"median\": 226\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0017\",\n          \"description\": \"nausea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0018\",\n          \"description\": \"fatigue\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0019\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 55,\n        \"ace_inhibitor_count\": 27,\n        \"metformin_count\": 21,\n        \"ppi_count\": 17,\n        \"nsaid_count\": 12,\n        \"other_count\": 38\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-014\",\n          \"description\": \"Informed consent version outdated by 1 revision\",\n          \"severity\": \"minor\",\n          \"site\": \"site_10\"\n        },\n        {\n          \"pd_id\": \"PD-015\",\n          \"description\": \"IP temperature excursion during shipment, 2h out of range\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_12\"\n        },\n        {\n          \"pd_id\": \"PD-016\",\n          \"description\": \"Lab sample mislabeled, corrected same day\",\n          \"severity\": \"minor\",\n          \"site\": \"site_04\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"All CRFs current through prior visit cycle\",\n        \"Query resolution rate at 94%\"\n      ],\n      \"events\": [\n        \"IRT randomization system verified, no anomalies\",\n        \"Bioanalytical lab shipment tracking confirmed for 1 samples\",\n        \"CRO quarterly oversight report submitted\"\n      ],\n      \"notes\": \"Week 6: Enrollment target met. All hepatic and renal panels within normal limits. 4 minor protocol deviations.\"\n    },\n    {\n      \"index\": 7,\n      \"date\": \"2024-04-15\",\n      \"enrollment\": {\n        \"total_randomized\": 160,\n        \"active\": 156,\n        \"screen_failures_cumulative\": 15,\n        \"withdrawals_cumulative\": 4,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_02\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_03\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_04\": {\n            \"enrolled\": 10,\n            \"active\": 10,\n            \"statin_concomitant\": 2\n          },\n          \"site_05\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          },\n          \"site_06\": {\n            \"enrolled\": 9,\n            \"active\": 9,\n            \"statin_concomitant\": 2\n          },\n          \"site_07\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          },\n          \"site_08\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_09\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 10,\n            \"active\": 10,\n            \"statin_concomitant\": 3\n          },\n          \"site_11\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 4\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 52,\n          \"alt_u_l\": {\n            \"mean\": 26.8,\n            \"median\": 24.1\n          },\n          \"ast_u_l\": {\n            \"mean\": 27.3,\n            \"median\": 26.7\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.64,\n            \"median\": 0.63\n          },\n          \"alp_u_l\": {\n            \"mean\": 80.7,\n            \"median\": 63.0\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.01,\n            \"median\": 0.91\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 15.3,\n            \"median\": 16.6\n          },\n          \"wbc_k\": {\n            \"mean\": 7.0,\n            \"median\": 6.1\n          },\n          \"platelets_k\": {\n            \"mean\": 239,\n            \"median\": 248\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 120,\n          \"alt_u_l\": {\n            \"mean\": 30.1,\n            \"median\": 29.6\n          },\n          \"ast_u_l\": {\n            \"mean\": 24.4,\n            \"median\": 24.3\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.76,\n            \"median\": 0.74\n          },\n          \"alp_u_l\": {\n            \"mean\": 56.6,\n            \"median\": 50.4\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.91,\n            \"median\": 0.95\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.1,\n            \"median\": 15.7\n          },\n          \"wbc_k\": {\n            \"mean\": 8.2,\n            \"median\": 7.0\n          },\n          \"platelets_k\": {\n            \"mean\": 248,\n            \"median\": 226\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0020\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0021\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0022\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 53,\n        \"ace_inhibitor_count\": 30,\n        \"metformin_count\": 22,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 11,\n        \"other_count\": 32\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-017\",\n          \"description\": \"Concomitant medication not recorded at visit\",\n          \"severity\": \"minor\",\n          \"site\": \"site_05\"\n        },\n        {\n          \"pd_id\": \"PD-018\",\n          \"description\": \"IP temperature excursion during shipment, 2h out of range\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_12\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"All SAE narratives submitted within reporting window\",\n        \"Study drug accountability reconciled, no discrepancies\"\n      ],\n      \"events\": [\n        \"Site 04 pharmacy temperature log reviewed: compliant\",\n        \"CRO quarterly oversight report submitted\",\n        \"EDC system maintenance window: 2h downtime Saturday 02:00 UTC\"\n      ],\n      \"notes\": \"Week 7: Enrollment target met. All hepatic and renal panels within normal limits. 3 minor protocol deviations.\"\n    },\n    {\n      \"index\": 8,\n      \"date\": \"2024-04-22\",\n      \"enrollment\": {\n        \"total_randomized\": 180,\n        \"active\": 177,\n        \"screen_failures_cumulative\": 13,\n        \"withdrawals_cumulative\": 3,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_02\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          },\n          \"site_03\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_04\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 3\n          },\n          \"site_06\": {\n            \"enrolled\": 10,\n            \"active\": 10,\n            \"statin_concomitant\": 2\n          },\n          \"site_07\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_08\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_11\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 52,\n          \"alt_u_l\": {\n            \"mean\": 25.0,\n            \"median\": 22.3\n          },\n          \"ast_u_l\": {\n            \"mean\": 20.6,\n            \"median\": 19.0\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.73,\n            \"median\": 0.7\n          },\n          \"alp_u_l\": {\n            \"mean\": 73.1,\n            \"median\": 76.4\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.81,\n            \"median\": 0.83\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 15.6,\n            \"median\": 12.5\n          },\n          \"wbc_k\": {\n            \"mean\": 6.0,\n            \"median\": 6.3\n          },\n          \"platelets_k\": {\n            \"mean\": 242,\n            \"median\": 244\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 130,\n          \"alt_u_l\": {\n            \"mean\": 28.6,\n            \"median\": 26.8\n          },\n          \"ast_u_l\": {\n            \"mean\": 22.5,\n            \"median\": 20.5\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.57,\n            \"median\": 0.54\n          },\n          \"alp_u_l\": {\n            \"mean\": 50.6,\n            \"median\": 66.5\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.07,\n            \"median\": 0.83\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.3,\n            \"median\": 16.2\n          },\n          \"wbc_k\": {\n            \"mean\": 6.8,\n            \"median\": 5.6\n          },\n          \"platelets_k\": {\n            \"mean\": 238,\n            \"median\": 233\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0023\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0024\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 56,\n        \"ace_inhibitor_count\": 29,\n        \"metformin_count\": 23,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 12,\n        \"other_count\": 33\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-019\",\n          \"description\": \"Blood draw outside protocol-specified fasting window\",\n          \"severity\": \"minor\",\n          \"site\": \"site_09\"\n        },\n        {\n          \"pd_id\": \"PD-020\",\n          \"description\": \"Concomitant medication not recorded at visit\",\n          \"severity\": \"minor\",\n          \"site\": \"site_04\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Study drug accountability reconciled, no discrepancies\",\n        \"All SAE narratives submitted within reporting window\",\n        \"No new safety signals identified this week by local PI\"\n      ],\n      \"events\": [\n        \"Site 06 monitoring visit completed, 2 findings\",\n        \"Regulatory submission packet sent to Site 05\",\n        \"IP resupply shipped to Sites 11, 12\"\n      ],\n      \"notes\": \"Week 8: Enrollment target met. All hepatic and renal panels within normal limits. 2 minor protocol deviations.\"\n    },\n    {\n      \"index\": 9,\n      \"date\": \"2024-04-29\",\n      \"enrollment\": {\n        \"total_randomized\": 185,\n        \"active\": 180,\n        \"screen_failures_cumulative\": 22,\n        \"withdrawals_cumulative\": 5,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_02\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          },\n          \"site_04\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_06\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 5\n          },\n          \"site_08\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_11\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          },\n          \"site_12\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 54,\n          \"alt_u_l\": {\n            \"mean\": 32.3,\n            \"median\": 31.9\n          },\n          \"ast_u_l\": {\n            \"mean\": 31.2,\n            \"median\": 31.2\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.56,\n            \"median\": 0.56\n          },\n          \"alp_u_l\": {\n            \"mean\": 66.5,\n            \"median\": 70.2\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.96,\n            \"median\": 0.83\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.3,\n            \"median\": 11.3\n          },\n          \"wbc_k\": {\n            \"mean\": 6.9,\n            \"median\": 7.6\n          },\n          \"platelets_k\": {\n            \"mean\": 238,\n            \"median\": 223\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 125,\n          \"alt_u_l\": {\n            \"mean\": 29.6,\n            \"median\": 28.4\n          },\n          \"ast_u_l\": {\n            \"mean\": 26.8,\n            \"median\": 25.8\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.84,\n            \"median\": 0.82\n          },\n          \"alp_u_l\": {\n            \"mean\": 59.9,\n            \"median\": 61.5\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.99,\n            \"median\": 0.95\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.4,\n            \"median\": 14.2\n          },\n          \"wbc_k\": {\n            \"mean\": 6.6,\n            \"median\": 6.1\n          },\n          \"platelets_k\": {\n            \"mean\": 220,\n            \"median\": 212\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0025\",\n          \"description\": \"nausea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0026\",\n          \"description\": \"nasopharyngitis\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0027\",\n          \"description\": \"abdominal discomfort\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0028\",\n          \"description\": \"abdominal discomfort\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 55,\n        \"ace_inhibitor_count\": 27,\n        \"metformin_count\": 23,\n        \"ppi_count\": 17,\n        \"nsaid_count\": 12,\n        \"other_count\": 35\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-021\",\n          \"description\": \"Informed consent version outdated by 1 revision\",\n          \"severity\": \"minor\",\n          \"site\": \"site_08\"\n        },\n        {\n          \"pd_id\": \"PD-022\",\n          \"description\": \"Dose modification without documented PI approval\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_10\"\n        },\n        {\n          \"pd_id\": \"PD-023\",\n          \"description\": \"Blood draw outside protocol-specified fasting window\",\n          \"severity\": \"minor\",\n          \"site\": \"site_05\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Enrollment on track per protocol timeline\",\n        \"Subject retention rate within protocol targets\"\n      ],\n      \"events\": [\n        \"Medical monitor weekly call completed\",\n        \"CRO quarterly oversight report submitted\"\n      ],\n      \"notes\": \"Week 9: Statin subgroup hepatic panel shows ALT values at upper range. Non-statin subgroup stable. Routine operations continue.\"\n    },\n    {\n      \"index\": 10,\n      \"date\": \"2024-05-06\",\n      \"enrollment\": {\n        \"total_randomized\": 184,\n        \"active\": 182,\n        \"screen_failures_cumulative\": 20,\n        \"withdrawals_cumulative\": 2,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_02\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_03\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          },\n          \"site_04\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 5\n          },\n          \"site_08\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_09\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 5\n          },\n          \"site_10\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_11\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 54,\n          \"alt_u_l\": {\n            \"mean\": 37.2,\n            \"median\": 35.2\n          },\n          \"ast_u_l\": {\n            \"mean\": 32.1,\n            \"median\": 30.9\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.68,\n            \"median\": 0.65\n          },\n          \"alp_u_l\": {\n            \"mean\": 65.1,\n            \"median\": 62.3\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.09,\n            \"median\": 0.88\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.8,\n            \"median\": 16.4\n          },\n          \"wbc_k\": {\n            \"mean\": 6.3,\n            \"median\": 6.7\n          },\n          \"platelets_k\": {\n            \"mean\": 245,\n            \"median\": 228\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 132,\n          \"alt_u_l\": {\n            \"mean\": 23.2,\n            \"median\": 22.4\n          },\n          \"ast_u_l\": {\n            \"mean\": 27.8,\n            \"median\": 25.9\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.4,\n            \"median\": 0.39\n          },\n          \"alp_u_l\": {\n            \"mean\": 59.6,\n            \"median\": 48.6\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.81,\n            \"median\": 0.98\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.4,\n            \"median\": 12.1\n          },\n          \"wbc_k\": {\n            \"mean\": 8.4,\n            \"median\": 7.1\n          },\n          \"platelets_k\": {\n            \"mean\": 261,\n            \"median\": 236\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0029\",\n          \"description\": \"nasopharyngitis\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0030\",\n          \"description\": \"dizziness\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0031\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0032\",\n          \"description\": \"transaminase measurement out of range\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 53,\n        \"ace_inhibitor_count\": 30,\n        \"metformin_count\": 24,\n        \"ppi_count\": 17,\n        \"nsaid_count\": 13,\n        \"other_count\": 35\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-024\",\n          \"description\": \"Incorrect lab panel order, repeated\",\n          \"severity\": \"minor\",\n          \"site\": \"site_07\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Training log updated for new study coordinator\",\n        \"Subject retention rate within protocol targets\",\n        \"Statin subgroup lab review: ALT mean 42 U/L, within 1.5x ULN; monitoring per protocol\"\n      ],\n      \"events\": [\n        \"EDC system maintenance window: 2h downtime Saturday 02:00 UTC\",\n        \"IP resupply shipped to Sites 11, 12\",\n        \"Site 12 monitoring visit completed, 4 findings\"\n      ],\n      \"notes\": \"Week 10: Statin subgroup hepatic panel shows ALT values at upper range. Non-statin subgroup stable. Routine operations continue.\"\n    },\n    {\n      \"index\": 11,\n      \"date\": \"2024-05-13\",\n      \"enrollment\": {\n        \"total_randomized\": 189,\n        \"active\": 182,\n        \"screen_failures_cumulative\": 27,\n        \"withdrawals_cumulative\": 7,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_02\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_03\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_06\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 21,\n            \"active\": 21,\n            \"statin_concomitant\": 6\n          },\n          \"site_08\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_09\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_11\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 55,\n          \"alt_u_l\": {\n            \"mean\": 47.6,\n            \"median\": 47.4\n          },\n          \"ast_u_l\": {\n            \"mean\": 35.8,\n            \"median\": 34.3\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.7,\n            \"median\": 0.67\n          },\n          \"alp_u_l\": {\n            \"mean\": 67.5,\n            \"median\": 61.8\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.8,\n            \"median\": 0.86\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.5,\n            \"median\": 15.1\n          },\n          \"wbc_k\": {\n            \"mean\": 6.7,\n            \"median\": 5.6\n          },\n          \"platelets_k\": {\n            \"mean\": 258,\n            \"median\": 256\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 132,\n          \"alt_u_l\": {\n            \"mean\": 29.3,\n            \"median\": 29.2\n          },\n          \"ast_u_l\": {\n            \"mean\": 25.5,\n            \"median\": 25.2\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.46,\n            \"median\": 0.44\n          },\n          \"alp_u_l\": {\n            \"mean\": 53.2,\n            \"median\": 50.8\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.96,\n            \"median\": 0.83\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.5,\n            \"median\": 11.1\n          },\n          \"wbc_k\": {\n            \"mean\": 6.7,\n            \"median\": 7.4\n          },\n          \"platelets_k\": {\n            \"mean\": 247,\n            \"median\": 232\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0033\",\n          \"description\": \"nausea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0034\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0035\",\n          \"description\": \"transaminase measurement out of range\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 51,\n        \"ace_inhibitor_count\": 26,\n        \"metformin_count\": 22,\n        \"ppi_count\": 17,\n        \"nsaid_count\": 12,\n        \"other_count\": 34\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-025\",\n          \"description\": \"Concomitant medication not recorded at visit\",\n          \"severity\": \"minor\",\n          \"site\": \"site_01\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Subject retention rate within protocol targets\",\n        \"EDC data entry backlog cleared, queries resolved\"\n      ],\n      \"events\": [\n        \"Drug accountability audit at Site 04: no discrepancies\",\n        \"Site 09 pharmacy temperature log reviewed: compliant\",\n        \"Central lab courier pickup schedule adjusted for holiday\"\n      ],\n      \"notes\": \"Week 11: Statin subgroup hepatic panel shows ALT values at upper range. Non-statin subgroup stable. Routine operations continue.\"\n    },\n    {\n      \"index\": 12,\n      \"date\": \"2024-05-20\",\n      \"enrollment\": {\n        \"total_randomized\": 192,\n        \"active\": 186,\n        \"screen_failures_cumulative\": 21,\n        \"withdrawals_cumulative\": 6,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_02\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_03\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 21,\n            \"active\": 21,\n            \"statin_concomitant\": 6\n          },\n          \"site_08\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_10\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 4\n          },\n          \"site_12\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 51,\n          \"alt_u_l\": {\n            \"mean\": 47.2,\n            \"median\": 45.7\n          },\n          \"ast_u_l\": {\n            \"mean\": 41.0,\n            \"median\": 41.0\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.73,\n            \"median\": 0.72\n          },\n          \"alp_u_l\": {\n            \"mean\": 61.9,\n            \"median\": 56.0\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.07,\n            \"median\": 0.92\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.8,\n            \"median\": 15.4\n          },\n          \"wbc_k\": {\n            \"mean\": 7.7,\n            \"median\": 7.1\n          },\n          \"platelets_k\": {\n            \"mean\": 257,\n            \"median\": 250\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 123,\n          \"alt_u_l\": {\n            \"mean\": 22.0,\n            \"median\": 21.4\n          },\n          \"ast_u_l\": {\n            \"mean\": 23.5,\n            \"median\": 22.1\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.66,\n            \"median\": 0.61\n          },\n          \"alp_u_l\": {\n            \"mean\": 55.2,\n            \"median\": 61.9\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.06,\n            \"median\": 0.98\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 14.8,\n            \"median\": 12.3\n          },\n          \"wbc_k\": {\n            \"mean\": 6.7,\n            \"median\": 5.6\n          },\n          \"platelets_k\": {\n            \"mean\": 234,\n            \"median\": 221\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0036\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0037\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0038\",\n          \"description\": \"abdominal discomfort\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0039\",\n          \"description\": \"transaminase measurement out of range\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 54,\n        \"ace_inhibitor_count\": 30,\n        \"metformin_count\": 23,\n        \"ppi_count\": 17,\n        \"nsaid_count\": 12,\n        \"other_count\": 36\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-026\",\n          \"description\": \"Dose modification without documented PI approval\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_07\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Source document verification complete for prior monitoring visit\",\n        \"EDC data entry backlog cleared, queries resolved\"\n      ],\n      \"events\": [\n        \"IVRS system update deployed, randomization unaffected\",\n        \"Bioanalytical lab shipment tracking confirmed for 2 samples\",\n        \"Site 03 new coordinator onboarding completed\"\n      ],\n      \"notes\": \"Week 12: Statin subgroup hepatic panel shows ALT values at upper range. Non-statin subgroup stable. Routine operations continue.\"\n    },\n    {\n      \"index\": 13,\n      \"date\": \"2024-05-27\",\n      \"enrollment\": {\n        \"total_randomized\": 195,\n        \"active\": 191,\n        \"screen_failures_cumulative\": 29,\n        \"withdrawals_cumulative\": 4,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_02\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 4\n          },\n          \"site_05\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_06\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 21,\n            \"active\": 21,\n            \"statin_concomitant\": 6\n          },\n          \"site_08\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_10\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 52,\n          \"alt_u_l\": {\n            \"mean\": 52.4,\n            \"median\": 50.8\n          },\n          \"ast_u_l\": {\n            \"mean\": 45.0,\n            \"median\": 44.3\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.84,\n            \"median\": 0.82\n          },\n          \"alp_u_l\": {\n            \"mean\": 63.5,\n            \"median\": 55.7\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.83,\n            \"median\": 0.85\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.5,\n            \"median\": 12.2\n          },\n          \"wbc_k\": {\n            \"mean\": 8.4,\n            \"median\": 5.7\n          },\n          \"platelets_k\": {\n            \"mean\": 238,\n            \"median\": 231\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 124,\n          \"alt_u_l\": {\n            \"mean\": 20.7,\n            \"median\": 20.4\n          },\n          \"ast_u_l\": {\n            \"mean\": 18.1,\n            \"median\": 17.2\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.69,\n            \"median\": 0.66\n          },\n          \"alp_u_l\": {\n            \"mean\": 68.1,\n            \"median\": 60.8\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.84,\n            \"median\": 0.88\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.1,\n            \"median\": 14.5\n          },\n          \"wbc_k\": {\n            \"mean\": 8.5,\n            \"median\": 5.6\n          },\n          \"platelets_k\": {\n            \"mean\": 218,\n            \"median\": 232\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0040\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0041\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0042\",\n          \"description\": \"nausea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0043\",\n          \"description\": \"transaminase measurement out of range\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0044\",\n          \"description\": \"transaminase measurement out of range\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 52,\n        \"ace_inhibitor_count\": 29,\n        \"metformin_count\": 23,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 12,\n        \"other_count\": 38\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-027\",\n          \"description\": \"Missed visit window (3 days late)\",\n          \"severity\": \"minor\",\n          \"site\": \"site_01\"\n        },\n        {\n          \"pd_id\": \"PD-028\",\n          \"description\": \"IP temperature excursion during shipment, 2h out of range\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_08\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Training log updated for new study coordinator\",\n        \"All CRFs current through prior visit cycle\",\n        \"Statin co-administered cohort ALT mean 58 U/L; values remain below 2x ULN action threshold\"\n      ],\n      \"events\": [\n        \"IP resupply shipped to Sites 06, 02\",\n        \"Site 10 monitoring visit completed, 2 findings\"\n      ],\n      \"notes\": \"Week 13: Statin subgroup hepatic panel shows ALT values at upper range. Non-statin subgroup stable. Routine operations continue.\"\n    },\n    {\n      \"index\": 14,\n      \"date\": \"2024-06-03\",\n      \"enrollment\": {\n        \"total_randomized\": 192,\n        \"active\": 182,\n        \"screen_failures_cumulative\": 28,\n        \"withdrawals_cumulative\": 10,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_02\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 4\n          },\n          \"site_04\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 11,\n            \"active\": 11,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 21,\n            \"active\": 21,\n            \"statin_concomitant\": 6\n          },\n          \"site_08\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_09\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_10\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 53,\n          \"alt_u_l\": {\n            \"mean\": 57.6,\n            \"median\": 56.0\n          },\n          \"ast_u_l\": {\n            \"mean\": 45.7,\n            \"median\": 45.7\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.86,\n            \"median\": 0.83\n          },\n          \"alp_u_l\": {\n            \"mean\": 65.4,\n            \"median\": 57.0\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.89,\n            \"median\": 0.85\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 14.7,\n            \"median\": 13.1\n          },\n          \"wbc_k\": {\n            \"mean\": 6.2,\n            \"median\": 7.0\n          },\n          \"platelets_k\": {\n            \"mean\": 223,\n            \"median\": 223\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 124,\n          \"alt_u_l\": {\n            \"mean\": 29.4,\n            \"median\": 27.5\n          },\n          \"ast_u_l\": {\n            \"mean\": 26.6,\n            \"median\": 25.1\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.43,\n            \"median\": 0.41\n          },\n          \"alp_u_l\": {\n            \"mean\": 74.1,\n            \"median\": 70.2\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.98,\n            \"median\": 0.96\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.8,\n            \"median\": 12.4\n          },\n          \"wbc_k\": {\n            \"mean\": 7.7,\n            \"median\": 6.6\n          },\n          \"platelets_k\": {\n            \"mean\": 259,\n            \"median\": 226\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0045\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0046\",\n          \"description\": \"back pain\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0047\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0048\",\n          \"description\": \"transaminase measurement out of range\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0049\",\n          \"description\": \"abdominal discomfort\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 55,\n        \"ace_inhibitor_count\": 28,\n        \"metformin_count\": 21,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 12,\n        \"other_count\": 36\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-029\",\n          \"description\": \"Blood draw outside protocol-specified fasting window\",\n          \"severity\": \"minor\",\n          \"site\": \"site_06\"\n        },\n        {\n          \"pd_id\": \"PD-030\",\n          \"description\": \"Lab sample mislabeled, corrected same day\",\n          \"severity\": \"minor\",\n          \"site\": \"site_02\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Lab kits inventory adequate for next 4 weeks\",\n        \"Subject retention rate within protocol targets\",\n        \"EDC data entry backlog cleared, queries resolved\"\n      ],\n      \"events\": [\n        \"CRO quarterly oversight report submitted\",\n        \"Medical monitor weekly call completed\",\n        \"Central lab courier pickup schedule adjusted for holiday\",\n        \"Site 07: ALT analyzer service notification, recalibration pending\"\n      ],\n      \"notes\": \"Week 14: Site 07 ALT analyzer flagged for recalibration. Statin subgroup ALT values at 1.5-2x ULN.\"\n    },\n    {\n      \"index\": 15,\n      \"date\": \"2024-06-10\",\n      \"enrollment\": {\n        \"total_randomized\": 215,\n        \"active\": 208,\n        \"screen_failures_cumulative\": 33,\n        \"withdrawals_cumulative\": 7,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 22,\n            \"active\": 22,\n            \"statin_concomitant\": 5\n          },\n          \"site_02\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 23,\n            \"active\": 23,\n            \"statin_concomitant\": 7\n          },\n          \"site_08\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 54,\n          \"alt_u_l\": {\n            \"mean\": 62.2,\n            \"median\": 61.3\n          },\n          \"ast_u_l\": {\n            \"mean\": 51.0,\n            \"median\": 50.3\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.89,\n            \"median\": 0.86\n          },\n          \"alp_u_l\": {\n            \"mean\": 58.6,\n            \"median\": 78.4\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.97,\n            \"median\": 0.8\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 14.8,\n            \"median\": 16.3\n          },\n          \"wbc_k\": {\n            \"mean\": 6.4,\n            \"median\": 7.9\n          },\n          \"platelets_k\": {\n            \"mean\": 241,\n            \"median\": 212\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 125,\n          \"alt_u_l\": {\n            \"mean\": 26.0,\n            \"median\": 25.2\n          },\n          \"ast_u_l\": {\n            \"mean\": 22.2,\n            \"median\": 21.0\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.64,\n            \"median\": 0.59\n          },\n          \"alp_u_l\": {\n            \"mean\": 65.4,\n            \"median\": 71.5\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.86,\n            \"median\": 0.86\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 12.5,\n            \"median\": 16.1\n          },\n          \"wbc_k\": {\n            \"mean\": 5.9,\n            \"median\": 6.9\n          },\n          \"platelets_k\": {\n            \"mean\": 229,\n            \"median\": 227\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0050\",\n          \"description\": \"back pain\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0051\",\n          \"description\": \"nasopharyngitis\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0052\",\n          \"description\": \"arthralgia\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0053\",\n          \"description\": \"transaminase measurement out of range\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0054\",\n          \"description\": \"transaminase measurement out of range\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 52,\n        \"ace_inhibitor_count\": 27,\n        \"metformin_count\": 23,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 12,\n        \"other_count\": 35\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-031\",\n          \"description\": \"Dose modification without documented PI approval\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_11\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Study drug accountability reconciled, no discrepancies\",\n        \"Central lab results received within 48h turnaround\",\n        \"Site 07 ALT re-assay ordered for 8 specimens, calibration offset confirmed\"\n      ],\n      \"events\": [\n        \"Drug accountability audit at Site 12: no discrepancies\",\n        \"IP resupply shipped to Sites 07, 03\",\n        \"Site 07 lab re-assay requested for 8 specimens flagged during calibration review\"\n      ],\n      \"notes\": \"Week 15: Site 07 re-assay ordered. Statin subgroup hepatic values persist across sites.\"\n    },\n    {\n      \"index\": 16,\n      \"date\": \"2024-06-17\",\n      \"enrollment\": {\n        \"total_randomized\": 204,\n        \"active\": 198,\n        \"screen_failures_cumulative\": 47,\n        \"withdrawals_cumulative\": 6,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 6\n          },\n          \"site_02\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 4\n          },\n          \"site_05\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 22,\n            \"active\": 22,\n            \"statin_concomitant\": 6\n          },\n          \"site_08\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 3\n          },\n          \"site_09\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 6\n          },\n          \"site_12\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 56,\n          \"alt_u_l\": {\n            \"mean\": 76.2,\n            \"median\": 75.3\n          },\n          \"ast_u_l\": {\n            \"mean\": 59.0,\n            \"median\": 57.6\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 1.02,\n            \"median\": 0.99\n          },\n          \"alp_u_l\": {\n            \"mean\": 76.1,\n            \"median\": 69.4\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.99,\n            \"median\": 0.83\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 12.2,\n            \"median\": 14.8\n          },\n          \"wbc_k\": {\n            \"mean\": 7.0,\n            \"median\": 6.4\n          },\n          \"platelets_k\": {\n            \"mean\": 233,\n            \"median\": 230\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 129,\n          \"alt_u_l\": {\n            \"mean\": 24.7,\n            \"median\": 22.8\n          },\n          \"ast_u_l\": {\n            \"mean\": 21.9,\n            \"median\": 20.9\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.64,\n            \"median\": 0.62\n          },\n          \"alp_u_l\": {\n            \"mean\": 71.7,\n            \"median\": 56.6\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.93,\n            \"median\": 0.89\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.1,\n            \"median\": 14.2\n          },\n          \"wbc_k\": {\n            \"mean\": 7.1,\n            \"median\": 7.4\n          },\n          \"platelets_k\": {\n            \"mean\": 245,\n            \"median\": 230\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0055\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0056\",\n          \"description\": \"arthralgia\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0057\",\n          \"description\": \"jaundice\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0058\",\n          \"description\": \"nausea\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 51,\n        \"ace_inhibitor_count\": 26,\n        \"metformin_count\": 23,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 12,\n        \"other_count\": 35\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-032\",\n          \"description\": \"Incorrect lab panel order, repeated\",\n          \"severity\": \"minor\",\n          \"site\": \"site_09\"\n        },\n        {\n          \"pd_id\": \"PD-033\",\n          \"description\": \"Eligibility criterion reassessed, subject confirmed eligible\",\n          \"severity\": \"minor\",\n          \"site\": \"site_02\"\n        },\n        {\n          \"pd_id\": \"PD-034\",\n          \"description\": \"Lab sample mislabeled, corrected same day\",\n          \"severity\": \"minor\",\n          \"site\": \"site_03\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"No new safety signals identified this week by local PI\",\n        \"Study drug accountability reconciled, no discrepancies\",\n        \"Regulatory binder audit: all documents current\",\n        \"Site 07 re-assay results: 6/8 specimens confirmed within 5% of original, 2 specimens offset by 12-15%\"\n      ],\n      \"events\": [\n        \"Central lab courier pickup schedule adjusted for holiday\",\n        \"Medical monitor weekly call completed\"\n      ],\n      \"notes\": \"Week 16: Site 07 re-assay complete; instrument offset confirmed for 2 of 8 specimens. Statin subgroup ALT approaching 2-3x ULN at multiple sites.\"\n    },\n    {\n      \"index\": 17,\n      \"date\": \"2024-06-24\",\n      \"enrollment\": {\n        \"total_randomized\": 225,\n        \"active\": 214,\n        \"screen_failures_cumulative\": 30,\n        \"withdrawals_cumulative\": 11,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 23,\n            \"active\": 23,\n            \"statin_concomitant\": 7\n          },\n          \"site_02\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_03\": {\n            \"enrolled\": 21,\n            \"active\": 21,\n            \"statin_concomitant\": 6\n          },\n          \"site_04\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 24,\n            \"active\": 24,\n            \"statin_concomitant\": 7\n          },\n          \"site_08\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 21,\n            \"active\": 21,\n            \"statin_concomitant\": 7\n          },\n          \"site_12\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 53,\n          \"alt_u_l\": {\n            \"mean\": 89.1,\n            \"median\": 86.5\n          },\n          \"ast_u_l\": {\n            \"mean\": 65.7,\n            \"median\": 63.9\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 1.13,\n            \"median\": 1.1\n          },\n          \"alp_u_l\": {\n            \"mean\": 80.0,\n            \"median\": 75.0\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.88,\n            \"median\": 0.86\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.0,\n            \"median\": 16.5\n          },\n          \"wbc_k\": {\n            \"mean\": 7.9,\n            \"median\": 6.9\n          },\n          \"platelets_k\": {\n            \"mean\": 249,\n            \"median\": 243\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 130,\n          \"alt_u_l\": {\n            \"mean\": 29.6,\n            \"median\": 29.5\n          },\n          \"ast_u_l\": {\n            \"mean\": 21.7,\n            \"median\": 20.8\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.46,\n            \"median\": 0.42\n          },\n          \"alp_u_l\": {\n            \"mean\": 68.4,\n            \"median\": 62.2\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.9,\n            \"median\": 0.89\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 15.7,\n            \"median\": 15.3\n          },\n          \"wbc_k\": {\n            \"mean\": 8.0,\n            \"median\": 5.7\n          },\n          \"platelets_k\": {\n            \"mean\": 252,\n            \"median\": 230\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0059\",\n          \"description\": \"back pain\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0060\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0061\",\n          \"description\": \"hepatic enzyme measurement out of range\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0062\",\n          \"description\": \"nausea\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0063\",\n          \"description\": \"abdominal pain\",\n          \"grade\": 2,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 54,\n        \"ace_inhibitor_count\": 26,\n        \"metformin_count\": 22,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 13,\n        \"other_count\": 34\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-035\",\n          \"description\": \"Informed consent version outdated by 1 revision\",\n          \"severity\": \"minor\",\n          \"site\": \"site_10\"\n        },\n        {\n          \"pd_id\": \"PD-036\",\n          \"description\": \"Eligibility criterion reassessed, subject confirmed eligible\",\n          \"severity\": \"minor\",\n          \"site\": \"site_04\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Lab kits inventory adequate for next 4 weeks\",\n        \"Enrollment on track per protocol timeline\",\n        \"Site pharmacy inventory verified\"\n      ],\n      \"events\": [\n        \"Medical monitor weekly call completed\",\n        \"Central lab courier pickup schedule adjusted for holiday\"\n      ],\n      \"notes\": \"Week 17: Statin subgroup hepatic enzymes 2-3x ULN across sites. SAE reports under review. Non-statin subgroup within range.\"\n    },\n    {\n      \"index\": 18,\n      \"date\": \"2024-07-01\",\n      \"enrollment\": {\n        \"total_randomized\": 210,\n        \"active\": 204,\n        \"screen_failures_cumulative\": 53,\n        \"withdrawals_cumulative\": 6,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 21,\n            \"active\": 21,\n            \"statin_concomitant\": 7\n          },\n          \"site_02\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_05\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 4\n          },\n          \"site_07\": {\n            \"enrolled\": 23,\n            \"active\": 23,\n            \"statin_concomitant\": 6\n          },\n          \"site_08\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_09\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_10\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_11\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 4\n          },\n          \"site_12\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 53,\n          \"alt_u_l\": {\n            \"mean\": 90.2,\n            \"median\": 88.7\n          },\n          \"ast_u_l\": {\n            \"mean\": 69.2,\n            \"median\": 69.1\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 1.44,\n            \"median\": 1.43\n          },\n          \"alp_u_l\": {\n            \"mean\": 83.4,\n            \"median\": 76.7\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.85,\n            \"median\": 0.87\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.2,\n            \"median\": 14.6\n          },\n          \"wbc_k\": {\n            \"mean\": 6.8,\n            \"median\": 7.6\n          },\n          \"platelets_k\": {\n            \"mean\": 225,\n            \"median\": 215\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 120,\n          \"alt_u_l\": {\n            \"mean\": 25.7,\n            \"median\": 23.9\n          },\n          \"ast_u_l\": {\n            \"mean\": 18.7,\n            \"median\": 17.5\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.64,\n            \"median\": 0.64\n          },\n          \"alp_u_l\": {\n            \"mean\": 52.5,\n            \"median\": 54.2\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.87,\n            \"median\": 0.95\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.1,\n            \"median\": 16.5\n          },\n          \"wbc_k\": {\n            \"mean\": 6.6,\n            \"median\": 6.9\n          },\n          \"platelets_k\": {\n            \"mean\": 256,\n            \"median\": 255\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0064\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0065\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0066\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0067\",\n          \"description\": \"back pain\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0068\",\n          \"description\": \"abdominal pain\",\n          \"grade\": 2,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0069\",\n          \"description\": \"fatigue\",\n          \"grade\": 2,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0070\",\n          \"description\": \"Hy's Law case: ALT 4.2x ULN, total bilirubin 2.8x ULN\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 53,\n        \"ace_inhibitor_count\": 26,\n        \"metformin_count\": 23,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 13,\n        \"other_count\": 38\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-037\",\n          \"description\": \"Informed consent version outdated by 1 revision\",\n          \"severity\": \"minor\",\n          \"site\": \"site_06\"\n        },\n        {\n          \"pd_id\": \"PD-038\",\n          \"description\": \"Blood draw outside protocol-specified fasting window\",\n          \"severity\": \"minor\",\n          \"site\": \"site_10\"\n        },\n        {\n          \"pd_id\": \"PD-039\",\n          \"description\": \"IP temperature excursion during shipment, 2h out of range\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_10\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Central lab results received within 48h turnaround\",\n        \"Source document verification complete for prior monitoring visit\",\n        \"Site pharmacy inventory verified\",\n        \"SAE report filed: subject 07-118, statin subgroup, ALT 4.2x ULN with bilirubin 2.8x ULN\",\n        \"Statin subgroup hepatic panel mean ALT 95 U/L across 8 sites\"\n      ],\n      \"events\": [\n        \"Data management plan revision v2.5 distributed\",\n        \"Data management plan revision v2.2 distributed\",\n        \"Site 08 monitoring visit completed, 3 findings\",\n        \"SAE report submitted to sponsor safety group within 24h\"\n      ],\n      \"notes\": \"Week 18: Statin subgroup hepatic enzymes 2-3x ULN across sites. SAE reports under review. Non-statin subgroup within range.\"\n    },\n    {\n      \"index\": 19,\n      \"date\": \"2024-07-08\",\n      \"enrollment\": {\n        \"total_randomized\": 202,\n        \"active\": 196,\n        \"screen_failures_cumulative\": 37,\n        \"withdrawals_cumulative\": 6,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 6\n          },\n          \"site_02\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 3\n          },\n          \"site_03\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 22,\n            \"active\": 22,\n            \"statin_concomitant\": 7\n          },\n          \"site_08\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          },\n          \"site_11\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 54,\n          \"alt_u_l\": {\n            \"mean\": 103.2,\n            \"median\": 100.3\n          },\n          \"ast_u_l\": {\n            \"mean\": 73.7,\n            \"median\": 73.6\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 1.56,\n            \"median\": 1.53\n          },\n          \"alp_u_l\": {\n            \"mean\": 74.1,\n            \"median\": 69.1\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.82,\n            \"median\": 0.95\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.4,\n            \"median\": 13.0\n          },\n          \"wbc_k\": {\n            \"mean\": 7.8,\n            \"median\": 5.9\n          },\n          \"platelets_k\": {\n            \"mean\": 262,\n            \"median\": 233\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 120,\n          \"alt_u_l\": {\n            \"mean\": 24.5,\n            \"median\": 23.8\n          },\n          \"ast_u_l\": {\n            \"mean\": 23.2,\n            \"median\": 22.3\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.64,\n            \"median\": 0.62\n          },\n          \"alp_u_l\": {\n            \"mean\": 50.8,\n            \"median\": 56.3\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.04,\n            \"median\": 0.95\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 15.2,\n            \"median\": 12.9\n          },\n          \"wbc_k\": {\n            \"mean\": 5.7,\n            \"median\": 7.1\n          },\n          \"platelets_k\": {\n            \"mean\": 242,\n            \"median\": 227\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0071\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0072\",\n          \"description\": \"headache\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0073\",\n          \"description\": \"fatigue\",\n          \"grade\": 2,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0074\",\n          \"description\": \"fatigue\",\n          \"grade\": 2,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 52,\n        \"ace_inhibitor_count\": 28,\n        \"metformin_count\": 21,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 11,\n        \"other_count\": 36\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-040\",\n          \"description\": \"IP temperature excursion during shipment, 2h out of range\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_08\"\n        },\n        {\n          \"pd_id\": \"PD-041\",\n          \"description\": \"Concomitant medication not recorded at visit\",\n          \"severity\": \"minor\",\n          \"site\": \"site_07\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Training log updated for new study coordinator\",\n        \"EDC data entry backlog cleared, queries resolved\",\n        \"Cross-site review: statin subgroup ALT out of range at Sites 01, 03, 05, 07, 09, 11; non-statin subgroup within reference range at all sites\"\n      ],\n      \"events\": [\n        \"Drug accountability audit at Site 04: no discrepancies\",\n        \"IVRS system update deployed, randomization unaffected\",\n        \"Medical monitor weekly call completed\"\n      ],\n      \"notes\": \"Week 19: Statin subgroup hepatic enzymes 2-3x ULN across sites. SAE reports under review. Non-statin subgroup within range.\"\n    },\n    {\n      \"index\": 20,\n      \"date\": \"2024-07-15\",\n      \"enrollment\": {\n        \"total_randomized\": 216,\n        \"active\": 206,\n        \"screen_failures_cumulative\": 45,\n        \"withdrawals_cumulative\": 10,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 22,\n            \"active\": 22,\n            \"statin_concomitant\": 7\n          },\n          \"site_02\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_03\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 6\n          },\n          \"site_04\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_05\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 4\n          },\n          \"site_06\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 24,\n            \"active\": 24,\n            \"statin_concomitant\": 6\n          },\n          \"site_08\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_09\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 54,\n          \"alt_u_l\": {\n            \"mean\": 103.2,\n            \"median\": 102.1\n          },\n          \"ast_u_l\": {\n            \"mean\": 82.6,\n            \"median\": 81.2\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 1.87,\n            \"median\": 1.85\n          },\n          \"alp_u_l\": {\n            \"mean\": 79.2,\n            \"median\": 55.7\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.99,\n            \"median\": 1.0\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.9,\n            \"median\": 12.8\n          },\n          \"wbc_k\": {\n            \"mean\": 6.2,\n            \"median\": 6.1\n          },\n          \"platelets_k\": {\n            \"mean\": 219,\n            \"median\": 257\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 123,\n          \"alt_u_l\": {\n            \"mean\": 21.8,\n            \"median\": 20.2\n          },\n          \"ast_u_l\": {\n            \"mean\": 18.5,\n            \"median\": 16.6\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.67,\n            \"median\": 0.66\n          },\n          \"alp_u_l\": {\n            \"mean\": 64.9,\n            \"median\": 53.5\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.03,\n            \"median\": 0.97\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.2,\n            \"median\": 12.7\n          },\n          \"wbc_k\": {\n            \"mean\": 8.5,\n            \"median\": 7.6\n          },\n          \"platelets_k\": {\n            \"mean\": 257,\n            \"median\": 227\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0075\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0076\",\n          \"description\": \"dizziness\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0077\",\n          \"description\": \"jaundice\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0078\",\n          \"description\": \"hepatic enzyme measurement out of range\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0079\",\n          \"description\": \"Hy's Law case: ALT 3.8x ULN, total bilirubin 2.3x ULN\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 55,\n        \"ace_inhibitor_count\": 28,\n        \"metformin_count\": 21,\n        \"ppi_count\": 17,\n        \"nsaid_count\": 12,\n        \"other_count\": 33\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-042\",\n          \"description\": \"Blood draw outside protocol-specified fasting window\",\n          \"severity\": \"minor\",\n          \"site\": \"site_07\"\n        },\n        {\n          \"pd_id\": \"PD-043\",\n          \"description\": \"Dose modification without documented PI approval\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_06\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Central lab results received within 48h turnaround\",\n        \"Lab kits inventory adequate for next 4 weeks\",\n        \"SAE report filed: subject 03-042, statin subgroup, ALT 3.8x ULN with bilirubin 2.3x ULN\",\n        \"Pharmacology consult requested: CYP3A4 inhibition profile of LNS-4821 under review\"\n      ],\n      \"events\": [\n        \"Site 07 monitoring visit completed, 3 findings\",\n        \"Bioanalytical lab shipment tracking confirmed for 1 samples\",\n        \"Central lab courier pickup schedule adjusted for holiday\",\n        \"SAE report submitted to sponsor safety group and regulatory authority\"\n      ],\n      \"notes\": \"Week 20: Cross-site statin subgroup hepatic signal confirmed. DDI pharmacology review in progress.\"\n    },\n    {\n      \"index\": 21,\n      \"date\": \"2024-07-22\",\n      \"enrollment\": {\n        \"total_randomized\": 219,\n        \"active\": 209,\n        \"screen_failures_cumulative\": 35,\n        \"withdrawals_cumulative\": 10,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 22,\n            \"active\": 22,\n            \"statin_concomitant\": 5\n          },\n          \"site_02\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_05\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 24,\n            \"active\": 24,\n            \"statin_concomitant\": 6\n          },\n          \"site_08\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_10\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 6\n          },\n          \"site_12\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 54,\n          \"alt_u_l\": {\n            \"mean\": 111.7,\n            \"median\": 110.7\n          },\n          \"ast_u_l\": {\n            \"mean\": 86.1,\n            \"median\": 84.4\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 1.91,\n            \"median\": 1.9\n          },\n          \"alp_u_l\": {\n            \"mean\": 84.1,\n            \"median\": 61.6\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.06,\n            \"median\": 0.95\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 15.3,\n            \"median\": 15.5\n          },\n          \"wbc_k\": {\n            \"mean\": 6.9,\n            \"median\": 7.1\n          },\n          \"platelets_k\": {\n            \"mean\": 239,\n            \"median\": 236\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 120,\n          \"alt_u_l\": {\n            \"mean\": 25.8,\n            \"median\": 24.8\n          },\n          \"ast_u_l\": {\n            \"mean\": 28.8,\n            \"median\": 27.5\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.71,\n            \"median\": 0.71\n          },\n          \"alp_u_l\": {\n            \"mean\": 57.8,\n            \"median\": 48.6\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.87,\n            \"median\": 0.84\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.8,\n            \"median\": 15.3\n          },\n          \"wbc_k\": {\n            \"mean\": 8.4,\n            \"median\": 6.0\n          },\n          \"platelets_k\": {\n            \"mean\": 225,\n            \"median\": 253\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0080\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0081\",\n          \"description\": \"fatigue\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0082\",\n          \"description\": \"nausea\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0083\",\n          \"description\": \"fatigue\",\n          \"grade\": 2,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 56,\n        \"ace_inhibitor_count\": 29,\n        \"metformin_count\": 23,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 12,\n        \"other_count\": 36\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-044\",\n          \"description\": \"Dose modification without documented PI approval\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_03\"\n        },\n        {\n          \"pd_id\": \"PD-045\",\n          \"description\": \"Blood draw outside protocol-specified fasting window\",\n          \"severity\": \"minor\",\n          \"site\": \"site_10\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"No new safety signals identified this week by local PI\",\n        \"Study drug accountability reconciled, no discrepancies\",\n        \"Multi-site pattern confirmed: ALT out of range in statin co-administered patients independent of site\"\n      ],\n      \"events\": [\n        \"IVRS system update deployed, randomization unaffected\",\n        \"Regulatory submission packet sent to Site 08\"\n      ],\n      \"notes\": \"Week 21: Cross-site statin subgroup hepatic signal confirmed. DDI pharmacology review in progress.\"\n    },\n    {\n      \"index\": 22,\n      \"date\": \"2024-07-29\",\n      \"enrollment\": {\n        \"total_randomized\": 236,\n        \"active\": 230,\n        \"screen_failures_cumulative\": 50,\n        \"withdrawals_cumulative\": 6,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 24,\n            \"active\": 24,\n            \"statin_concomitant\": 7\n          },\n          \"site_02\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_03\": {\n            \"enrolled\": 22,\n            \"active\": 22,\n            \"statin_concomitant\": 7\n          },\n          \"site_04\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_05\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 6\n          },\n          \"site_06\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 26,\n            \"active\": 26,\n            \"statin_concomitant\": 6\n          },\n          \"site_08\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 6\n          },\n          \"site_10\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 22,\n            \"active\": 22,\n            \"statin_concomitant\": 7\n          },\n          \"site_12\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 4\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 52,\n          \"alt_u_l\": {\n            \"mean\": 123.1,\n            \"median\": 121.0\n          },\n          \"ast_u_l\": {\n            \"mean\": 89.3,\n            \"median\": 88.8\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 2.2,\n            \"median\": 2.2\n          },\n          \"alp_u_l\": {\n            \"mean\": 77.8,\n            \"median\": 67.6\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.97,\n            \"median\": 0.88\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.8,\n            \"median\": 11.6\n          },\n          \"wbc_k\": {\n            \"mean\": 7.7,\n            \"median\": 6.7\n          },\n          \"platelets_k\": {\n            \"mean\": 261,\n            \"median\": 243\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 129,\n          \"alt_u_l\": {\n            \"mean\": 28.6,\n            \"median\": 27.4\n          },\n          \"ast_u_l\": {\n            \"mean\": 30.0,\n            \"median\": 29.0\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.53,\n            \"median\": 0.51\n          },\n          \"alp_u_l\": {\n            \"mean\": 54.6,\n            \"median\": 58.8\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.1,\n            \"median\": 0.9\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.2,\n            \"median\": 12.5\n          },\n          \"wbc_k\": {\n            \"mean\": 7.1,\n            \"median\": 6.6\n          },\n          \"platelets_k\": {\n            \"mean\": 247,\n            \"median\": 227\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0084\",\n          \"description\": \"headache\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0085\",\n          \"description\": \"nasopharyngitis\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0086\",\n          \"description\": \"dizziness\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0087\",\n          \"description\": \"hepatic enzyme measurement out of range\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0088\",\n          \"description\": \"hepatic enzyme measurement out of range\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 53,\n        \"ace_inhibitor_count\": 30,\n        \"metformin_count\": 24,\n        \"ppi_count\": 17,\n        \"nsaid_count\": 13,\n        \"other_count\": 35\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-046\",\n          \"description\": \"Lab sample mislabeled, corrected same day\",\n          \"severity\": \"minor\",\n          \"site\": \"site_10\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Central lab results received within 48h turnaround\",\n        \"All SAE narratives submitted within reporting window\",\n        \"IEC/IRB annual renewal submitted on schedule\"\n      ],\n      \"events\": [\n        \"Site 09 new coordinator onboarding completed\",\n        \"Regulatory submission packet sent to Site 11\",\n        \"Site 01 new coordinator onboarding completed\"\n      ],\n      \"notes\": \"Week 22: Cross-site statin subgroup hepatic signal confirmed. DDI pharmacology review in progress.\"\n    },\n    {\n      \"index\": 23,\n      \"date\": \"2024-08-05\",\n      \"enrollment\": {\n        \"total_randomized\": 210,\n        \"active\": 196,\n        \"screen_failures_cumulative\": 58,\n        \"withdrawals_cumulative\": 14,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 21,\n            \"active\": 21,\n            \"statin_concomitant\": 7\n          },\n          \"site_02\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 6\n          },\n          \"site_04\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 12,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 23,\n            \"active\": 22,\n            \"statin_concomitant\": 7\n          },\n          \"site_08\": {\n            \"enrolled\": 16,\n            \"active\": 15,\n            \"statin_concomitant\": 5\n          },\n          \"site_09\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_11\": {\n            \"enrolled\": 19,\n            \"active\": 18,\n            \"statin_concomitant\": 4\n          },\n          \"site_12\": {\n            \"enrolled\": 16,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 52,\n          \"alt_u_l\": {\n            \"mean\": 127.9,\n            \"median\": 125.2\n          },\n          \"ast_u_l\": {\n            \"mean\": 91.5,\n            \"median\": 91.0\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 1.92,\n            \"median\": 1.9\n          },\n          \"alp_u_l\": {\n            \"mean\": 64.0,\n            \"median\": 73.5\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.95,\n            \"median\": 0.91\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.8,\n            \"median\": 11.3\n          },\n          \"wbc_k\": {\n            \"mean\": 6.7,\n            \"median\": 6.4\n          },\n          \"platelets_k\": {\n            \"mean\": 257,\n            \"median\": 235\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 127,\n          \"alt_u_l\": {\n            \"mean\": 27.9,\n            \"median\": 27.8\n          },\n          \"ast_u_l\": {\n            \"mean\": 27.3,\n            \"median\": 26.0\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.51,\n            \"median\": 0.49\n          },\n          \"alp_u_l\": {\n            \"mean\": 61.8,\n            \"median\": 54.5\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.94,\n            \"median\": 0.81\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.2,\n            \"median\": 14.7\n          },\n          \"wbc_k\": {\n            \"mean\": 7.7,\n            \"median\": 7.0\n          },\n          \"platelets_k\": {\n            \"mean\": 231,\n            \"median\": 214\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0089\",\n          \"description\": \"dizziness\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0090\",\n          \"description\": \"nausea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0091\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0092\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0093\",\n          \"description\": \"jaundice\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0094\",\n          \"description\": \"drug-induced liver injury\",\n          \"grade\": 3,\n          \"relatedness\": \"definitely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 55,\n        \"ace_inhibitor_count\": 29,\n        \"metformin_count\": 21,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 12,\n        \"other_count\": 32\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-047\",\n          \"description\": \"Missed visit window (2 days late)\",\n          \"severity\": \"minor\",\n          \"site\": \"site_11\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Training log updated for new study coordinator\",\n        \"Lab kits inventory adequate for next 4 weeks\",\n        \"No new safety signals identified this week by local PI\",\n        \"PK sub-study interim: LNS-4821 plasma concentration data consistent with CYP3A4 inhibition; atorvastatin AUC 3.2x in co-administered subjects\"\n      ],\n      \"events\": [\n        \"CRO quarterly oversight report submitted\",\n        \"Drug accountability audit at Site 04: no discrepancies\",\n        \"PK sub-study interim data package distributed to DSMB members\"\n      ],\n      \"notes\": \"Week 23: PK data supports CYP3A4 inhibition mechanism. Statin subgroup ALT 3-4x ULN.\"\n    },\n    {\n      \"index\": 24,\n      \"date\": \"2024-08-12\",\n      \"enrollment\": {\n        \"total_randomized\": 244,\n        \"active\": 236,\n        \"screen_failures_cumulative\": 49,\n        \"withdrawals_cumulative\": 8,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 25,\n            \"active\": 25,\n            \"statin_concomitant\": 6\n          },\n          \"site_02\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_03\": {\n            \"enrolled\": 22,\n            \"active\": 22,\n            \"statin_concomitant\": 7\n          },\n          \"site_04\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_05\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_07\": {\n            \"enrolled\": 27,\n            \"active\": 27,\n            \"statin_concomitant\": 8\n          },\n          \"site_08\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_09\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 6\n          },\n          \"site_10\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 22,\n            \"active\": 22,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 53,\n          \"alt_u_l\": {\n            \"mean\": 133.5,\n            \"median\": 131.2\n          },\n          \"ast_u_l\": {\n            \"mean\": 98.1,\n            \"median\": 96.3\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 2.08,\n            \"median\": 2.05\n          },\n          \"alp_u_l\": {\n            \"mean\": 71.4,\n            \"median\": 70.4\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.97,\n            \"median\": 0.9\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.8,\n            \"median\": 16.2\n          },\n          \"wbc_k\": {\n            \"mean\": 6.9,\n            \"median\": 7.4\n          },\n          \"platelets_k\": {\n            \"mean\": 253,\n            \"median\": 237\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 120,\n          \"alt_u_l\": {\n            \"mean\": 21.8,\n            \"median\": 20.0\n          },\n          \"ast_u_l\": {\n            \"mean\": 19.6,\n            \"median\": 18.7\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.79,\n            \"median\": 0.74\n          },\n          \"alp_u_l\": {\n            \"mean\": 52.3,\n            \"median\": 69.0\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.94,\n            \"median\": 0.84\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 15.3,\n            \"median\": 12.6\n          },\n          \"wbc_k\": {\n            \"mean\": 8.0,\n            \"median\": 7.6\n          },\n          \"platelets_k\": {\n            \"mean\": 248,\n            \"median\": 246\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0095\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0096\",\n          \"description\": \"fatigue\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0097\",\n          \"description\": \"nausea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0098\",\n          \"description\": \"headache\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0099\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0100\",\n          \"description\": \"jaundice\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 55,\n        \"ace_inhibitor_count\": 27,\n        \"metformin_count\": 22,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 13,\n        \"other_count\": 38\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-048\",\n          \"description\": \"Eligibility criterion reassessed, subject confirmed eligible\",\n          \"severity\": \"minor\",\n          \"site\": \"site_11\"\n        },\n        {\n          \"pd_id\": \"PD-049\",\n          \"description\": \"Lab sample mislabeled, corrected same day\",\n          \"severity\": \"minor\",\n          \"site\": \"site_08\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"IEC/IRB annual renewal submitted on schedule\",\n        \"Central lab results received within 48h turnaround\",\n        \"Query resolution rate at 94%\",\n        \"DSMB teleconference scheduled; cross-site statin subgroup hepatic data package compiled\"\n      ],\n      \"events\": [\n        \"CRO quarterly oversight report submitted\",\n        \"IVRS system update deployed, randomization unaffected\",\n        \"DSMB meeting materials finalized and transmitted\"\n      ],\n      \"notes\": \"Week 24: DSMB review pending. Statin subgroup hepatic data compiled across all sites.\"\n    },\n    {\n      \"index\": 25,\n      \"date\": \"2024-08-19\",\n      \"enrollment\": {\n        \"total_randomized\": 231,\n        \"active\": 216,\n        \"screen_failures_cumulative\": 42,\n        \"withdrawals_cumulative\": 15,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 23,\n            \"active\": 22,\n            \"statin_concomitant\": 6\n          },\n          \"site_02\": {\n            \"enrolled\": 17,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_03\": {\n            \"enrolled\": 21,\n            \"active\": 21,\n            \"statin_concomitant\": 6\n          },\n          \"site_04\": {\n            \"enrolled\": 15,\n            \"active\": 14,\n            \"statin_concomitant\": 5\n          },\n          \"site_05\": {\n            \"enrolled\": 19,\n            \"active\": 18,\n            \"statin_concomitant\": 4\n          },\n          \"site_06\": {\n            \"enrolled\": 13,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 25,\n            \"active\": 25,\n            \"statin_concomitant\": 8\n          },\n          \"site_08\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 19,\n            \"active\": 18,\n            \"statin_concomitant\": 6\n          },\n          \"site_10\": {\n            \"enrolled\": 15,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 21,\n            \"active\": 20,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 56,\n          \"alt_u_l\": {\n            \"mean\": 152.0,\n            \"median\": 150.5\n          },\n          \"ast_u_l\": {\n            \"mean\": 98.1,\n            \"median\": 97.3\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 2.41,\n            \"median\": 2.41\n          },\n          \"alp_u_l\": {\n            \"mean\": 63.2,\n            \"median\": 66.9\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.09,\n            \"median\": 0.85\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 12.9,\n            \"median\": 11.7\n          },\n          \"wbc_k\": {\n            \"mean\": 7.5,\n            \"median\": 7.2\n          },\n          \"platelets_k\": {\n            \"mean\": 241,\n            \"median\": 246\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 122,\n          \"alt_u_l\": {\n            \"mean\": 21.7,\n            \"median\": 21.0\n          },\n          \"ast_u_l\": {\n            \"mean\": 25.6,\n            \"median\": 23.7\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.89,\n            \"median\": 0.87\n          },\n          \"alp_u_l\": {\n            \"mean\": 67.1,\n            \"median\": 59.1\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.89,\n            \"median\": 0.96\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.3,\n            \"median\": 14.8\n          },\n          \"wbc_k\": {\n            \"mean\": 8.0,\n            \"median\": 6.2\n          },\n          \"platelets_k\": {\n            \"mean\": 251,\n            \"median\": 243\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0101\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0102\",\n          \"description\": \"back pain\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0103\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0104\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0105\",\n          \"description\": \"drug-induced liver injury\",\n          \"grade\": 3,\n          \"relatedness\": \"definitely related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0106\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 52,\n        \"ace_inhibitor_count\": 28,\n        \"metformin_count\": 22,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 11,\n        \"other_count\": 38\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-050\",\n          \"description\": \"Eligibility criterion reassessed, subject confirmed eligible\",\n          \"severity\": \"minor\",\n          \"site\": \"site_02\"\n        },\n        {\n          \"pd_id\": \"PD-051\",\n          \"description\": \"IP temperature excursion during shipment, 2h out of range\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_10\"\n        },\n        {\n          \"pd_id\": \"PD-052\",\n          \"description\": \"Missed visit window (4 days late)\",\n          \"severity\": \"minor\",\n          \"site\": \"site_01\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Query resolution rate at 94%\",\n        \"All CRFs current through prior visit cycle\",\n        \"DDI mechanism confirmed: LNS-4821 CYP3A4 inhibition leads to statin accumulation; protocol amendment drafted to exclude statin co-administration\"\n      ],\n      \"events\": [\n        \"Site 01 new coordinator onboarding completed\",\n        \"Data management plan revision v2.5 distributed\",\n        \"CRO quarterly oversight report submitted\",\n        \"Protocol amendment v4.0 drafted; sponsor medical review initiated\"\n      ],\n      \"notes\": \"Week 25: DDI confirmed. Protocol amendment drafted to exclude statin co-administration.\"\n    },\n    {\n      \"index\": 26,\n      \"date\": \"2024-08-26\",\n      \"enrollment\": {\n        \"total_randomized\": 234,\n        \"active\": 220,\n        \"screen_failures_cumulative\": 69,\n        \"withdrawals_cumulative\": 14,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 24,\n            \"active\": 23,\n            \"statin_concomitant\": 6\n          },\n          \"site_02\": {\n            \"enrolled\": 17,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_03\": {\n            \"enrolled\": 22,\n            \"active\": 21,\n            \"statin_concomitant\": 7\n          },\n          \"site_04\": {\n            \"enrolled\": 16,\n            \"active\": 15,\n            \"statin_concomitant\": 5\n          },\n          \"site_05\": {\n            \"enrolled\": 19,\n            \"active\": 18,\n            \"statin_concomitant\": 6\n          },\n          \"site_06\": {\n            \"enrolled\": 13,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 25,\n            \"active\": 24,\n            \"statin_concomitant\": 8\n          },\n          \"site_08\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 19,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_10\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_11\": {\n            \"enrolled\": 22,\n            \"active\": 21,\n            \"statin_concomitant\": 6\n          },\n          \"site_12\": {\n            \"enrolled\": 17,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 52,\n          \"alt_u_l\": {\n            \"mean\": 148.8,\n            \"median\": 148.6\n          },\n          \"ast_u_l\": {\n            \"mean\": 104.7,\n            \"median\": 102.9\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 2.32,\n            \"median\": 2.32\n          },\n          \"alp_u_l\": {\n            \"mean\": 81.8,\n            \"median\": 62.7\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.01,\n            \"median\": 0.89\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 15.9,\n            \"median\": 12.0\n          },\n          \"wbc_k\": {\n            \"mean\": 6.1,\n            \"median\": 6.5\n          },\n          \"platelets_k\": {\n            \"mean\": 260,\n            \"median\": 247\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 132,\n          \"alt_u_l\": {\n            \"mean\": 31.3,\n            \"median\": 31.2\n          },\n          \"ast_u_l\": {\n            \"mean\": 29.1,\n            \"median\": 28.1\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.89,\n            \"median\": 0.87\n          },\n          \"alp_u_l\": {\n            \"mean\": 58.0,\n            \"median\": 69.6\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.0,\n            \"median\": 0.91\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.6,\n            \"median\": 12.0\n          },\n          \"wbc_k\": {\n            \"mean\": 7.5,\n            \"median\": 5.9\n          },\n          \"platelets_k\": {\n            \"mean\": 232,\n            \"median\": 238\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0107\",\n          \"description\": \"back pain\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0108\",\n          \"description\": \"nausea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0109\",\n          \"description\": \"fatigue\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0110\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 46,\n        \"ace_inhibitor_count\": 28,\n        \"metformin_count\": 23,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 12,\n        \"other_count\": 37\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-053\",\n          \"description\": \"Concomitant medication not recorded at visit\",\n          \"severity\": \"minor\",\n          \"site\": \"site_05\"\n        },\n        {\n          \"pd_id\": \"PD-054\",\n          \"description\": \"Dose modification without documented PI approval\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_07\"\n        },\n        {\n          \"pd_id\": \"PD-055\",\n          \"description\": \"Informed consent version outdated by 1 revision\",\n          \"severity\": \"minor\",\n          \"site\": \"site_03\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Study drug accountability reconciled, no discrepancies\",\n        \"All CRFs current through prior visit cycle\",\n        \"Protocol amendment v4.0 submitted to IRB: statin exclusion criterion added, CYP3A4 substrate screening required\",\n        \"In-vitro CYP3A4 Ki data received: LNS-4821 Ki = 0.8 uM, consistent with clinical DDI magnitude\"\n      ],\n      \"events\": [\n        \"CRO quarterly oversight report submitted\",\n        \"Site 06 new coordinator onboarding completed\",\n        \"Investigator meeting minutes distributed\",\n        \"Protocol amendment v4.0 submitted to central IRB\"\n      ],\n      \"notes\": \"Week 26: Protocol amendment v4.0 under IRB review/approval. Statin subjects transitioning.\"\n    },\n    {\n      \"index\": 27,\n      \"date\": \"2024-09-02\",\n      \"enrollment\": {\n        \"total_randomized\": 218,\n        \"active\": 202,\n        \"screen_failures_cumulative\": 68,\n        \"withdrawals_cumulative\": 16,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 22,\n            \"active\": 21,\n            \"statin_concomitant\": 6\n          },\n          \"site_02\": {\n            \"enrolled\": 16,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 20,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 3\n          },\n          \"site_05\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 13,\n            \"active\": 12,\n            \"statin_concomitant\": 4\n          },\n          \"site_07\": {\n            \"enrolled\": 24,\n            \"active\": 24,\n            \"statin_concomitant\": 7\n          },\n          \"site_08\": {\n            \"enrolled\": 16,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_10\": {\n            \"enrolled\": 14,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 20,\n            \"active\": 19,\n            \"statin_concomitant\": 6\n          },\n          \"site_12\": {\n            \"enrolled\": 16,\n            \"active\": 15,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 53,\n          \"alt_u_l\": {\n            \"mean\": 162.5,\n            \"median\": 160.5\n          },\n          \"ast_u_l\": {\n            \"mean\": 108.1,\n            \"median\": 106.5\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 2.44,\n            \"median\": 2.41\n          },\n          \"alp_u_l\": {\n            \"mean\": 69.2,\n            \"median\": 55.0\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.98,\n            \"median\": 0.99\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 17.4,\n            \"median\": 15.0\n          },\n          \"wbc_k\": {\n            \"mean\": 8.2,\n            \"median\": 7.6\n          },\n          \"platelets_k\": {\n            \"mean\": 236,\n            \"median\": 223\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 129,\n          \"alt_u_l\": {\n            \"mean\": 22.1,\n            \"median\": 21.7\n          },\n          \"ast_u_l\": {\n            \"mean\": 23.2,\n            \"median\": 21.7\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.63,\n            \"median\": 0.62\n          },\n          \"alp_u_l\": {\n            \"mean\": 52.7,\n            \"median\": 53.7\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.82,\n            \"median\": 0.99\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.9,\n            \"median\": 15.8\n          },\n          \"wbc_k\": {\n            \"mean\": 8.0,\n            \"median\": 7.5\n          },\n          \"platelets_k\": {\n            \"mean\": 232,\n            \"median\": 213\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0111\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0112\",\n          \"description\": \"fatigue\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0113\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0114\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 38,\n        \"ace_inhibitor_count\": 30,\n        \"metformin_count\": 23,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 12,\n        \"other_count\": 32\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-056\",\n          \"description\": \"Incorrect lab panel order, repeated\",\n          \"severity\": \"minor\",\n          \"site\": \"site_10\"\n        },\n        {\n          \"pd_id\": \"PD-057\",\n          \"description\": \"IP temperature excursion during shipment, 2h out of range\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_06\"\n        },\n        {\n          \"pd_id\": \"PD-058\",\n          \"description\": \"Blood draw outside protocol-specified fasting window\",\n          \"severity\": \"minor\",\n          \"site\": \"site_08\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Query resolution rate at 94%\",\n        \"Central lab results received within 48h turnaround\",\n        \"IRB approved protocol amendment v4.0; all sites notified\",\n        \"Statin co-administered subjects transitioning off statins per amended protocol\"\n      ],\n      \"events\": [\n        \"IVRS system update deployed, randomization unaffected\",\n        \"Site 10 pharmacy temperature log reviewed: compliant\",\n        \"Protocol amendment v4.0 approved; site distribution initiated\"\n      ],\n      \"notes\": \"Week 27: Protocol amendment v4.0 under IRB review/approval. Statin subjects transitioning.\"\n    },\n    {\n      \"index\": 28,\n      \"date\": \"2024-09-09\",\n      \"enrollment\": {\n        \"total_randomized\": 220,\n        \"active\": 200,\n        \"screen_failures_cumulative\": 48,\n        \"withdrawals_cumulative\": 20,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 22,\n            \"active\": 21,\n            \"statin_concomitant\": 6\n          },\n          \"site_02\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 20,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_04\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_05\": {\n            \"enrolled\": 18,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 13,\n            \"active\": 12,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 24,\n            \"active\": 24,\n            \"statin_concomitant\": 8\n          },\n          \"site_08\": {\n            \"enrolled\": 16,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_09\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_10\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 20,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 16,\n            \"active\": 15,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 51,\n          \"alt_u_l\": {\n            \"mean\": 166.2,\n            \"median\": 164.2\n          },\n          \"ast_u_l\": {\n            \"mean\": 115.1,\n            \"median\": 113.9\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 2.84,\n            \"median\": 2.8\n          },\n          \"alp_u_l\": {\n            \"mean\": 67.4,\n            \"median\": 79.6\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.91,\n            \"median\": 0.86\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 12.2,\n            \"median\": 12.0\n          },\n          \"wbc_k\": {\n            \"mean\": 5.6,\n            \"median\": 7.3\n          },\n          \"platelets_k\": {\n            \"mean\": 242,\n            \"median\": 246\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 123,\n          \"alt_u_l\": {\n            \"mean\": 29.1,\n            \"median\": 28.5\n          },\n          \"ast_u_l\": {\n            \"mean\": 21.3,\n            \"median\": 20.1\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.58,\n            \"median\": 0.56\n          },\n          \"alp_u_l\": {\n            \"mean\": 57.4,\n            \"median\": 49.0\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.03,\n            \"median\": 0.89\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 12.9,\n            \"median\": 13.0\n          },\n          \"wbc_k\": {\n            \"mean\": 7.8,\n            \"median\": 6.4\n          },\n          \"platelets_k\": {\n            \"mean\": 256,\n            \"median\": 213\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0115\",\n          \"description\": \"dizziness\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0116\",\n          \"description\": \"insomnia\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0117\",\n          \"description\": \"diarrhea\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0118\",\n          \"description\": \"jaundice\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0119\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 31,\n        \"ace_inhibitor_count\": 28,\n        \"metformin_count\": 22,\n        \"ppi_count\": 19,\n        \"nsaid_count\": 12,\n        \"other_count\": 37\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-059\",\n          \"description\": \"Dose modification without documented PI approval\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_07\"\n        },\n        {\n          \"pd_id\": \"PD-060\",\n          \"description\": \"Dose modification without documented PI approval\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_12\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"EDC data entry backlog cleared, queries resolved\",\n        \"Study drug accountability reconciled, no discrepancies\",\n        \"Regulatory binder audit: all documents current\",\n        \"10 of 12 sites have implemented protocol amendment; 2 sites pending local IRB\"\n      ],\n      \"events\": [\n        \"Medical monitor weekly call completed\",\n        \"Bioanalytical lab shipment tracking confirmed for 4 samples\",\n        \"IVRS system update deployed, randomization unaffected\",\n        \"Site implementation tracking: 10/12 sites active on amended protocol\"\n      ],\n      \"notes\": \"Week 28: Amended protocol in effect at majority of sites. Hepatic monitoring frequency adjusted.\"\n    },\n    {\n      \"index\": 29,\n      \"date\": \"2024-09-16\",\n      \"enrollment\": {\n        \"total_randomized\": 222,\n        \"active\": 202,\n        \"screen_failures_cumulative\": 69,\n        \"withdrawals_cumulative\": 20,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 22,\n            \"active\": 21,\n            \"statin_concomitant\": 6\n          },\n          \"site_02\": {\n            \"enrolled\": 17,\n            \"active\": 16,\n            \"statin_concomitant\": 4\n          },\n          \"site_03\": {\n            \"enrolled\": 20,\n            \"active\": 20,\n            \"statin_concomitant\": 6\n          },\n          \"site_04\": {\n            \"enrolled\": 15,\n            \"active\": 15,\n            \"statin_concomitant\": 4\n          },\n          \"site_05\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 5\n          },\n          \"site_06\": {\n            \"enrolled\": 13,\n            \"active\": 12,\n            \"statin_concomitant\": 4\n          },\n          \"site_07\": {\n            \"enrolled\": 24,\n            \"active\": 24,\n            \"statin_concomitant\": 7\n          },\n          \"site_08\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_09\": {\n            \"enrolled\": 18,\n            \"active\": 18,\n            \"statin_concomitant\": 4\n          },\n          \"site_10\": {\n            \"enrolled\": 15,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 20,\n            \"active\": 19,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 52,\n          \"alt_u_l\": {\n            \"mean\": 171.6,\n            \"median\": 169.8\n          },\n          \"ast_u_l\": {\n            \"mean\": 118.2,\n            \"median\": 118.1\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 2.77,\n            \"median\": 2.74\n          },\n          \"alp_u_l\": {\n            \"mean\": 82.0,\n            \"median\": 68.1\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.87,\n            \"median\": 0.82\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 13.3,\n            \"median\": 11.4\n          },\n          \"wbc_k\": {\n            \"mean\": 8.2,\n            \"median\": 5.7\n          },\n          \"platelets_k\": {\n            \"mean\": 234,\n            \"median\": 228\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 126,\n          \"alt_u_l\": {\n            \"mean\": 21.3,\n            \"median\": 21.0\n          },\n          \"ast_u_l\": {\n            \"mean\": 19.4,\n            \"median\": 18.3\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.52,\n            \"median\": 0.49\n          },\n          \"alp_u_l\": {\n            \"mean\": 69.3,\n            \"median\": 68.1\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.85,\n            \"median\": 0.91\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.6,\n            \"median\": 12.7\n          },\n          \"wbc_k\": {\n            \"mean\": 6.4,\n            \"median\": 7.6\n          },\n          \"platelets_k\": {\n            \"mean\": 232,\n            \"median\": 258\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0120\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0121\",\n          \"description\": \"nasopharyngitis\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0122\",\n          \"description\": \"back pain\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0123\",\n          \"description\": \"arthralgia\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0124\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0125\",\n          \"description\": \"jaundice\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0126\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 23,\n        \"ace_inhibitor_count\": 30,\n        \"metformin_count\": 22,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 13,\n        \"other_count\": 35\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-061\",\n          \"description\": \"Missed visit window (2 days late)\",\n          \"severity\": \"minor\",\n          \"site\": \"site_09\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Source document verification complete for prior monitoring visit\",\n        \"Training log updated for new study coordinator\",\n        \"All sites now operating under amended protocol v4.0\"\n      ],\n      \"events\": [\n        \"Site 12 monitoring visit completed, 1 findings\",\n        \"Drug accountability audit at Site 05: no discrepancies\"\n      ],\n      \"notes\": \"Week 29: Amended protocol in effect at majority of sites. Hepatic monitoring frequency adjusted.\"\n    },\n    {\n      \"index\": 30,\n      \"date\": \"2024-09-23\",\n      \"enrollment\": {\n        \"total_randomized\": 224,\n        \"active\": 207,\n        \"screen_failures_cumulative\": 78,\n        \"withdrawals_cumulative\": 17,\n        \"sites\": {\n          \"site_01\": {\n            \"enrolled\": 22,\n            \"active\": 21,\n            \"statin_concomitant\": 5\n          },\n          \"site_02\": {\n            \"enrolled\": 17,\n            \"active\": 16,\n            \"statin_concomitant\": 5\n          },\n          \"site_03\": {\n            \"enrolled\": 21,\n            \"active\": 20,\n            \"statin_concomitant\": 6\n          },\n          \"site_04\": {\n            \"enrolled\": 15,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_05\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 6\n          },\n          \"site_06\": {\n            \"enrolled\": 13,\n            \"active\": 13,\n            \"statin_concomitant\": 3\n          },\n          \"site_07\": {\n            \"enrolled\": 24,\n            \"active\": 23,\n            \"statin_concomitant\": 7\n          },\n          \"site_08\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 5\n          },\n          \"site_09\": {\n            \"enrolled\": 19,\n            \"active\": 19,\n            \"statin_concomitant\": 6\n          },\n          \"site_10\": {\n            \"enrolled\": 15,\n            \"active\": 14,\n            \"statin_concomitant\": 4\n          },\n          \"site_11\": {\n            \"enrolled\": 21,\n            \"active\": 21,\n            \"statin_concomitant\": 5\n          },\n          \"site_12\": {\n            \"enrolled\": 17,\n            \"active\": 17,\n            \"statin_concomitant\": 4\n          }\n        }\n      },\n      \"lab_panels\": {\n        \"statin_subgroup\": {\n          \"n\": 52,\n          \"alt_u_l\": {\n            \"mean\": 181.8,\n            \"median\": 179.2\n          },\n          \"ast_u_l\": {\n            \"mean\": 120.0,\n            \"median\": 119.0\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 3.1,\n            \"median\": 3.1\n          },\n          \"alp_u_l\": {\n            \"mean\": 57.0,\n            \"median\": 75.7\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 0.96,\n            \"median\": 0.96\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 16.1,\n            \"median\": 13.6\n          },\n          \"wbc_k\": {\n            \"mean\": 7.8,\n            \"median\": 6.3\n          },\n          \"platelets_k\": {\n            \"mean\": 219,\n            \"median\": 249\n          }\n        },\n        \"non_statin_subgroup\": {\n          \"n\": 131,\n          \"alt_u_l\": {\n            \"mean\": 28.8,\n            \"median\": 26.9\n          },\n          \"ast_u_l\": {\n            \"mean\": 28.3,\n            \"median\": 27.9\n          },\n          \"bilirubin_mg_dl\": {\n            \"mean\": 0.6,\n            \"median\": 0.56\n          },\n          \"alp_u_l\": {\n            \"mean\": 67.0,\n            \"median\": 64.9\n          },\n          \"creatinine_mg_dl\": {\n            \"mean\": 1.02,\n            \"median\": 0.97\n          },\n          \"bun_mg_dl\": {\n            \"mean\": 14.1,\n            \"median\": 13.9\n          },\n          \"wbc_k\": {\n            \"mean\": 6.3,\n            \"median\": 7.9\n          },\n          \"platelets_k\": {\n            \"mean\": 252,\n            \"median\": 229\n          }\n        }\n      },\n      \"adverse_events\": [\n        {\n          \"ae_id\": \"AE-0127\",\n          \"description\": \"upper respiratory infection\",\n          \"grade\": 1,\n          \"relatedness\": \"not related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0128\",\n          \"description\": \"fatigue\",\n          \"grade\": 1,\n          \"relatedness\": \"unlikely related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0129\",\n          \"description\": \"headache\",\n          \"grade\": 1,\n          \"relatedness\": \"possibly related\",\n          \"resolved\": true,\n          \"subject_group\": \"non_statin\"\n        },\n        {\n          \"ae_id\": \"AE-0130\",\n          \"description\": \"jaundice\",\n          \"grade\": 2,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0131\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": true,\n          \"subject_group\": \"statin\"\n        },\n        {\n          \"ae_id\": \"AE-0132\",\n          \"description\": \"hepatocellular injury\",\n          \"grade\": 3,\n          \"relatedness\": \"probably related\",\n          \"resolved\": false,\n          \"subject_group\": \"statin\"\n        }\n      ],\n      \"concomitant_meds\": {\n        \"statin_count\": 14,\n        \"ace_inhibitor_count\": 29,\n        \"metformin_count\": 22,\n        \"ppi_count\": 18,\n        \"nsaid_count\": 11,\n        \"other_count\": 32\n      },\n      \"protocol_deviations\": [\n        {\n          \"pd_id\": \"PD-062\",\n          \"description\": \"IP temperature excursion during shipment, 2h out of range\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_06\"\n        },\n        {\n          \"pd_id\": \"PD-063\",\n          \"description\": \"Dose modification without documented PI approval\",\n          \"severity\": \"moderate\",\n          \"site\": \"site_03\"\n        }\n      ],\n      \"investigator_notes\": [\n        \"Enrollment on track per protocol timeline\",\n        \"All CRFs current through prior visit cycle\",\n        \"Post-amendment statin subgroup n=8 (subjects who could not discontinue); hepatic monitoring frequency doubled\"\n      ],\n      \"events\": [\n        \"Drug accountability audit at Site 05: no discrepancies\",\n        \"Investigator meeting minutes distributed\",\n        \"End-of-phase safety data compilation initiated for regulatory briefing\"\n      ],\n      \"notes\": \"Week 30: Amended protocol in effect at majority of sites. Hepatic monitoring frequency adjusted.\"\n    }\n  ]\n}",
  "metadata": {
    "episode_count": 30,
    "source": "pre-generated",
    "layer_name": "outline",
    "layer_level": 1,
    "build_fingerprint": {
      "scheme": "synix:build:v1",
      "digest": "f2034ad3bb3a7e5c8863c56a14ab2e64f4322839e5ca9d1e313b91f59e748164",
      "components": {
        "transform": "95b93afff1fd0996ff411e91087777e346ee1d11967fb0b147a9ed652c56d2ca",
        "inputs": "adb73f1617b2cb78"
      }
    },
    "transform_fingerprint": {
      "scheme": "synix:transform:v2",
      "digest": "95b93afff1fd0996ff411e91087777e346ee1d11967fb0b147a9ed652c56d2ca",
      "components": {
        "transform_id": "b34546bdc16464ec",
        "source": "c6a454d687ba7eb1",
        "model": "9bc2ebe12e4c88f9"
      }
    }
  }
}